Disease on EC 2.7.1.199 - protein-Npi-phosphohistidine-D-glucose phosphotransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
22q11 Deletion Syndrome
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Abortion, Spontaneous
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.
Acidosis
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Acidosis
Proteomic Profiling of the Effect of Metabolic Acidosis on the Apical Membrane of the Proximal Convoluted Tubule.
Acidosis, Lactic
Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation.
Acquired Immunodeficiency Syndrome
Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block.
Acute Kidney Injury
Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.
Adenocarcinoma
Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1?, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Adenocarcinoma
Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Adenocarcinoma
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Adenocarcinoma
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Adenocarcinoma
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Adenocarcinoma
Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Adenocarcinoma
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
Adenocarcinoma
Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma.
Adenocarcinoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Adenocarcinoma
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Adenocarcinoma
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.
Adenocarcinoma
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.
Adenocarcinoma
Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
Adenocarcinoma
Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia.
Adenocarcinoma
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Adenocarcinoma
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Adenocarcinoma
Operable Non-Small Cell Lung Cancer: Correlation of Volumetric Helical Dynamic Contrast-enhanced CT Parameters with Immunohistochemical Markers of Tumor Hypoxia.
Adenocarcinoma
Significance of Glucose Transporter Type 1 (GLUT-1) Expression in the Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
Adenocarcinoma
[Expression of glucose transporter protein 1 and desmin in reactive mesothelial hyperplasia and epithelioid malignant mesothelioma].
Adenocarcinoma
¹?F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Adenocarcinoma of Lung
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Adenocarcinoma of Lung
Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
Adenocarcinoma of Lung
Down-Regulation of Hypoxia-Inducible Factor-1? and Downstream Glucose Transporter Protein-1 Gene by ?-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.
Adenocarcinoma of Lung
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Adenocarcinoma of Lung
Low glucose transporter SLC2A5-inhibited human normal adjacent lung adenocarcinoma cytoplasmic pro-B cell development mechanism network.
Adenocarcinoma of Lung
MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway.
Adenocarcinoma of Lung
Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Adenocarcinoma of Lung
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Adenocarcinoma of Lung
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.
Adenocarcinoma of Lung
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
Adenoma
Both butyrate incubation and hypoxia upregulate genes involved in the ruminal transport of SCFA and their metabolites.
Adenoma
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
Adenoma
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Adenoma
GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
Adenoma
MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.
Adenoma
Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
Adenoma, Islet Cell
Abnormal facilitative glucose transporter gene expression in human islet cell tumors.
Adenoma, Liver Cell
Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2).
Adenoma, Pleomorphic
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Adenoviridae Infections
Maintaining HNF6 expression prevents AdHNF3beta-mediated decrease in hepatic levels of Glut-2 and glycogen.
Adrenocortical Carcinoma
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Adrenocortical Carcinoma
Oncocytic Adrenocortical Carcinoma With Low 18F-FDG Uptake and the Absence of Glucose Transporter 1 Expression.
Adrenoleukodystrophy
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Altitude Sickness
Overexpression of genes associated with hypoxia in cattle adapted to Trans Himalayan region of Ladakh.
Alzheimer Disease
Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.
Alzheimer Disease
Akt and cAMP response element binding protein mediate 17?-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line.
Alzheimer Disease
Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Alzheimer Disease
CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease.
Alzheimer Disease
Expression of the glucose transporter GLUT12 in Alzheimer's disease patients.
Alzheimer Disease
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.
Alzheimer Disease
Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease.
Alzheimer Disease
Long-term Oral Galactose Treatment Prevents Cognitive Deficits in Male Wistar Rats Treated Intracerebroventricularly with Streptozotocin.
Alzheimer Disease
Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.
Alzheimer Disease
Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease.
Alzheimer Disease
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Alzheimer Disease
[Immunohistochemistry using antibody to the glucose transporter 3 in human brainstem and cerebellar tissues]
Ameloblastoma
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Anemia
Anemia in Glucose Transporter Type 1 Deficiency Syndrome: Often Expected, Rarely Encountered, and with a Fascinating Explanation.
Aneurysm
Medial Hypoxia and Adventitial Vasa Vasorum Remodeling in Human Ascending Aortic Aneurysm.
Arthritis
Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis.
Arthritis, Experimental
Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectin and visfatin in rat adjuvant induced arthritis.
Arthritis, Rheumatoid
Influence of genetic copy number variants of the human GLUT3 glucose transporter gene SLC2A3 on protein expression, glycolysis and rheumatoid arthritis risk: A genetic replication study.
Astrocytoma
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
Astrocytoma
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
Ataxia
A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia.
Ataxia
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Ataxia
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Ataxia
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Ataxia
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Ataxia
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
Ataxia
Intermittent Ataxia with Early Onset Absence Epilepsy in Glucose Transporter Type 1 Deficiency Syndrome.
Ataxia
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Ataxia Telangiectasia
ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
Atherosclerosis
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Bile Duct Neoplasms
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Biotinidase Deficiency
Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.
Brain Diseases
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Brain Diseases
Disease-associated Glut1 single amino acid substitute mutations S66F, R126C, and T295M constitute Glut1-deficiency states in vitro.
Brain Diseases
Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro.
Brain Diseases
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Brain Diseases
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Brain Diseases
Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature.
Brain Diseases
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
Brain Diseases
GLUT1 deficiency links nutrient availability and apoptosis during embryonic development.
Brain Diseases
Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome.
Brain Diseases
The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.
Brain Diseases, Metabolic
A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome.
Brain Diseases, Metabolic
A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia.
Brain Diseases, Metabolic
GLUT1-deficiency syndrome: Report of a four-generation Norwegian family with a mild phenotype.
Brain Diseases, Metabolic
Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet.
Brain Edema
Expression of GLUT3 and HIF-1? in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.
Brain Injuries
Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.
Brain Injuries
Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice.
Brain Injuries, Traumatic
Increased expression of neuronal glucose transporter 3 but not glial glucose transporter 1 following severe diffuse traumatic brain injury in rats.
Brain Ischemia
Aged garlic extract and S-allylcysteine increase the GLUT3 and GCLC expression levels in cerebral ischemia.
Brain Ischemia
Cerebral ischemia affects glucose transporter kinetics across rat brain microvascular endothelium: quantitative analysis by an in situ brain perfusion method.
Brain Ischemia
Cerebral ischemia alters glucose transporter kinetics across rat brain microvascular endothelium. Quantitative analysis by an in situ brain perfusion method.
Brain Ischemia
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Brain Ischemia
Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia.
Brain Ischemia
Progressive hippocampal loss of immunoreactive GLUT3, the neuron-specific glucose transporter, after global forebrain ischemia in the rat.
Brain Neoplasms
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Brain Neoplasms
Expression of facilitative glucose transporter isoforms in human brain tumors.
Brain Neoplasms
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Brain Neoplasms
Site-directed deletion of a 10-nucleotide domain of the 3'-untranslated region of the GLUT1 glucose transporter mRNA eliminates cytosolic protein binding in human brain tumors and induction of reporter gene expression.
Brain Neoplasms
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
Breast Neoplasms
Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
Breast Neoplasms
AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.
Breast Neoplasms
Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.
Breast Neoplasms
Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.
Breast Neoplasms
Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.
Breast Neoplasms
Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
Breast Neoplasms
Detection of human breast cancer cells using a 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles.
Breast Neoplasms
Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients.
Breast Neoplasms
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Breast Neoplasms
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.
Breast Neoplasms
Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells.
Breast Neoplasms
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.
Breast Neoplasms
Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Breast Neoplasms
Expression of glucose transporter GLUT-1 and estrogen receptors ER-alpha and ER-beta in human breast cancer.
Breast Neoplasms
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Breast Neoplasms
Fatty acid-bearing albumin but not fatty acid-depleted albumin induces HIF-1 activation in human renal proximal tubular epithelial cell line HK-2.
Breast Neoplasms
Glucose erythrocyte transporter in women with breast cancer: changes in lipid composition of erythrocyte membrane.
Breast Neoplasms
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Breast Neoplasms
Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.
Breast Neoplasms
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Breast Neoplasms
Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
Breast Neoplasms
GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Breast Neoplasms
GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation.
Breast Neoplasms
GLUT12 and adipose tissue: Expression, regulation and its relation with obesity in mice.
Breast Neoplasms
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.
Breast Neoplasms
Glycopolymer decorated multiwalled carbon nanotubes for dual targeted breast cancer therapy.
Breast Neoplasms
Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
Breast Neoplasms
Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes.
Breast Neoplasms
Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Breast Neoplasms
Immunohistochemical expression of melatonin receptor MT1 and glucose transporter GLUT1 in human breast cancer.
Breast Neoplasms
Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.
Breast Neoplasms
Increased expression of mitochondrial sodium-coupled ascorbic acid transporter-2 (mitSVCT2) as a central feature in breast cancer.
Breast Neoplasms
Influence of cycloheximide-mediated downregulation of glucose transport on TNF alpha-induced apoptosis.
Breast Neoplasms
Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5.
Breast Neoplasms
Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake.
Breast Neoplasms
Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Breast Neoplasms
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
Breast Neoplasms
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Breast Neoplasms
LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.
Breast Neoplasms
Loss of GLUT4 Induces Metabolic Reprogramming and Impairs Viability of Breast Cancer Cells.
Breast Neoplasms
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.
Breast Neoplasms
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Breast Neoplasms
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Breast Neoplasms
Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
Breast Neoplasms
Pioglitazone induces hypoxia-inducible factor 1 activation in human renal proximal tubular epithelial cell line HK-2.
Breast Neoplasms
Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Breast Neoplasms
Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.
Breast Neoplasms
Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.
Breast Neoplasms
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1? expression.
Breast Neoplasms
The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter.
Breast Neoplasms
The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
Breast Neoplasms
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.
Breast Neoplasms
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer.
Breast Neoplasms
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
Breast Neoplasms
[Expression of glucose transporter 1 in human breast carcinoma and its clinical significance]
Breast Neoplasms
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
Calcinosis
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Carcinogenesis
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Carcinogenesis
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Carcinogenesis
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
Carcinogenesis
Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Carcinogenesis
Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
Carcinogenesis
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Carcinogenesis
Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.
Carcinogenesis
Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
Carcinogenesis
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.
Carcinogenesis
Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Carcinogenesis
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Carcinogenesis
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Carcinogenesis
The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Carcinogenesis
Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Carcinoma
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Carcinoma
An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions.
Carcinoma
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Carcinoma
Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Carcinoma
Coexpression of hypoxia-inducible factor-1? and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Carcinoma
Construction of a GLUT-1 and HIF-1? gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
Carcinoma
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Carcinoma
Correspondence re: Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11:437-443.
Carcinoma
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Carcinoma
Diagnostic Value of Glucose Transporter 1 (GLUT-1) Expression in Nested Variant of Urothelial Carcinoma.
Carcinoma
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Carcinoma
Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity.
Carcinoma
Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Carcinoma
Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors.
Carcinoma
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Carcinoma
Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.
Carcinoma
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Carcinoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Carcinoma
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI.
Carcinoma
Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma.
Carcinoma
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Carcinoma
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Carcinoma
Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters.
Carcinoma
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Carcinoma
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Carcinoma
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Carcinoma
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
Carcinoma
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
Carcinoma
HIF-1? and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Carcinoma
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
Carcinoma
High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen.
Carcinoma
Histological and immunohistochemical evaluation of stroma variations and their correlation with the Ki-67 index and expressions of glucose transporter 1 and monocarboxylate transporter 1 in canine thyroid C-cell carcinomas.
Carcinoma
Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Carcinoma
Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Carcinoma
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Carcinoma
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Carcinoma
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Carcinoma
Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
Carcinoma
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
Carcinoma
LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake.
Carcinoma
Long non-coding RNA mortal obligate RNA transcript suppresses tumor cell proliferation in prostate carcinoma by inhibiting glucose uptake.
Carcinoma
Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma.
Carcinoma
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Carcinoma
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis.
Carcinoma
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Carcinoma
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo.
Carcinoma
Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.
Carcinoma
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Carcinoma
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Carcinoma
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Carcinoma
Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Carcinoma
Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
Carcinoma
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Carcinoma
Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Carcinoma
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Carcinoma
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Carcinoma
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Carcinoma
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Carcinoma
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Carcinoma
SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
Carcinoma
The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells.
Carcinoma
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Carcinoma
The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene.
Carcinoma
The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells.
Carcinoma
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Carcinoma
Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Carcinoma
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Carcinoma
Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Carcinoma
[Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis.]
Carcinoma
[Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
Carcinoma
[Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance]
Carcinoma
[Expression of hypoxia inducible factor-1? and correlated target genes in human laryngeal carcinoma].
Carcinoma
[Inhibition of Sirolimus on the growth of pancreatic carcinoma and its effect on the expression of glucose transporter and hexokinase ?].
Carcinoma, Adenoid Cystic
High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen.
Carcinoma, Ductal
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
Carcinoma, Ductal
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Carcinoma, Ehrlich Tumor
Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development.
Carcinoma, Hepatocellular
18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Carcinoma, Hepatocellular
A study of the regulation of the glucose transporter in the plasma membranes of hepatoma cells induced by 3'-Me DAB.
Carcinoma, Hepatocellular
Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
Carcinoma, Hepatocellular
C/EBP binding activity to site F of the rat GLUT2 glucose transporter gene promoter is attenuated by c-Jun in vitro.
Carcinoma, Hepatocellular
Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced ?-catenin activation.
Carcinoma, Hepatocellular
CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells.
Carcinoma, Hepatocellular
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Carcinoma, Hepatocellular
Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.
Carcinoma, Hepatocellular
Diacylglycerol kinase ? predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man.
Carcinoma, Hepatocellular
Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evidence for expression of the facilitated glucose transporter in rat hepatocytes.
Carcinoma, Hepatocellular
Expression of the human erythrocyte glucose transporter in Escherichia coli.
Carcinoma, Hepatocellular
FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Carcinoma, Hepatocellular
Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells.
Carcinoma, Hepatocellular
Pattern of glucose transporter (Glut 1) expression in embryonic brains is related to maturation of blood-brain barrier tightness.
Carcinoma, Hepatocellular
Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Quantitative immunocytochemistry (image analysis) of glucose transporters in the normal and postischemic rodent hippocampus.
Carcinoma, Hepatocellular
Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
Carcinoma, Hepatocellular
Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number.
Carcinoma, Hepatocellular
Role of the GLUT 2 glucose transporter in the response of the L-type pyruvate kinase gene to glucose in liver-derived cells.
Carcinoma, Hepatocellular
RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tissue-specific and de novo promoter methylation of the mouse glucose transporter 2.
Carcinoma, Hepatocellular
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
Carcinoma, Intraductal, Noninfiltrating
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
Carcinoma, Mucoepidermoid
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.
Carcinoma, Non-Small-Cell Lung
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression.
Carcinoma, Non-Small-Cell Lung
Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Carcinoma, Non-Small-Cell Lung
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Carcinoma, Non-Small-Cell Lung
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Carcinoma, Non-Small-Cell Lung
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Carcinoma, Non-Small-Cell Lung
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Carcinoma, Non-Small-Cell Lung
Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Carcinoma, Non-Small-Cell Lung
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy.
Carcinoma, Non-Small-Cell Lung
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
Carcinoma, Non-Small-Cell Lung
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Carcinoma, Non-Small-Cell Lung
[Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance]
Carcinoma, Pancreatic Ductal
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Carcinoma, Renal Cell
A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.
Carcinoma, Renal Cell
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Carcinoma, Renal Cell
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Carcinoma, Renal Cell
Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters.
Carcinoma, Renal Cell
Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.
Carcinoma, Renal Cell
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
Carcinoma, Renal Cell
Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.
Carcinoma, Renal Cell
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Carcinoma, Renal Cell
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Carcinoma, Renal Cell
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Carcinoma, Squamous Cell
18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Carcinoma, Squamous Cell
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Carcinoma, Squamous Cell
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Carcinoma, Squamous Cell
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Carcinoma, Squamous Cell
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
Carcinoma, Squamous Cell
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
Carcinoma, Squamous Cell
Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
Carcinoma, Squamous Cell
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Carcinoma, Squamous Cell
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis.
Carcinoma, Squamous Cell
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Carcinoma, Squamous Cell
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Carcinoma, Squamous Cell
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Carcinoma, Squamous Cell
Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Carcinoma, Transitional Cell
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Cardiomegaly
Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.
Cardiomegaly
Glucose transporter 4 (GLUT4) deficient hearts develop maladaptive hypertrophy in response to physiologic or pathologic stresses.
Cardiomegaly
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Cardiomyopathies
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.
Cardiomyopathies
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Cardiomyopathy, Dilated
Cardiac PPARalpha expression in patients with dilated cardiomyopathy.
Cardiomyopathy, Dilated
Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy.
Cardiovascular Diseases
Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis.
Cardiovascular Diseases
Effects of glucose and insulin on the H9c2 (2-1) cell proliferation may be mediated through regulating glucose transporter 4 expression.
Cardiovascular Diseases
SGLT2 inhibitors and the changing landscape for treatment of diabetes.
Cataract
Another Case of Glucose Transporter 1 Deficiency Syndrome with Periventricular Calcification, Cataracts, Hemolysis, and Pseudohyperkalemia.
Cerebral Hemorrhage
Analysis of glucose metabolism by 18F-FDG-PET imaging and glucose transporter expression in a mouse model of intracerebral hemorrhage.
Cerebral Hemorrhage
[Expression of glucose transporter 1 in the blood-brain barrier around hematoma in rats with cerebral hemorrhage]
Cerebral Infarction
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Cerebrovascular Disorders
Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease.
Cervical Intraepithelial Neoplasia
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Cholangiocarcinoma
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Cholangiocarcinoma
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Cholangiocarcinoma
Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas.
Cholangiocarcinoma
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Cholera
Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes.
Cholera
The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts.
Chondroblastoma
False positive (18)F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.
Choriocarcinoma
Adenoviral-Mediated Placental Gene Transfer of IGF-1 Corrects Placental Insufficiency via Enhanced Placental Glucose Transport Mechanisms.
Choriocarcinoma
Hyperglycemia regulates the glucose-transport system of clonal choriocarcinoma cells in vitro. A potential molecular mechanism contributing to the adjunct effect of glucose in tumor therapy.
Choriocarcinoma
Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1.
Choriocarcinoma
Transepithelial glucose transport and metabolism in BeWo choriocarcinoma cells.
Coccidiosis
Impacts of increasing challenge with Eimeria maxima on the growth performance and gene expression of biomarkers associated with intestinal integrity and nutrient transporters.
Colonic Neoplasms
Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.
Colonic Neoplasms
Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer.
Colonic Neoplasms
Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.
Colonic Neoplasms
Knockdown of Hypoxia-Inducible Factor 1? Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts.
Colonic Neoplasms
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Colonic Neoplasms
Overexpression of miRNA-143 Inhibits Colon Cancer Cell Proliferation by Inhibiting Glucose Uptake.
Colonic Neoplasms
Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
Colorectal Neoplasms
Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling.
Colorectal Neoplasms
Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Colorectal Neoplasms
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Colorectal Neoplasms
GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
Colorectal Neoplasms
HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Colorectal Neoplasms
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Colorectal Neoplasms
Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Colorectal Neoplasms
Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients.
Colorectal Neoplasms
RPS7 inhibits colorectal cancer growth via decreasing HIF-1?-mediated glycolysis.
Colorectal Neoplasms
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil.
Colorectal Neoplasms
Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
Colorectal Neoplasms
[Expression of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in colorectal cancer and clinicopathologic significance].
Congenital Abnormalities
Fanconi-Bickel syndrome--a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism.
Congenital Abnormalities
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Actual Insights into Treatable Inborn Errors of Metabolism Causing Epilepsy.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Neonatal hypoglycaemia: aetiologies.
Coronary Artery Disease
Title: Coronary artery disease is associated with higher epicardial Renitol binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.
Coronary Occlusion
Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.
COVID-19
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
COVID-19
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
Craniopharyngioma
Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study.
Cryptorchidism
Degenerative changes in spermatogonia are associated with loss of glucose transporter (Glut 3) in abdominal testis of surgically induced unilateral cryptorchidism in rats.
Cystic Fibrosis
Cl- channels regulate lipid droplet formation via Rab8a expression during adipocyte differentiation.
Cystic Fibrosis
Identification of the cofilin-binding sites in the large cytoplasmic domain of Na,K-ATPase.
Cysts
Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
Cysts
Hypoxia-inducible factor-1? causes renal cyst expansion through calcium-activated chloride secretion.
Cysts
Use of a murine embryonic stem cell line that is sensitive to high glucose environment to model neural tube development in diabetic pregnancy.
Death, Sudden, Cardiac
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
Dementia
Long-term Oral Galactose Treatment Prevents Cognitive Deficits in Male Wistar Rats Treated Intracerebroventricularly with Streptozotocin.
Dementia
Loss with ageing but preservation of frontal cortical capillary pericytes in post-stroke dementia, vascular dementia and Alzheimer's disease.
Dentigerous Cyst
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Diabetes Complications
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Diabetes Complications
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
Diabetes Complications
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Diabetes Mellitus
(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice.
Diabetes Mellitus
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
Diabetes Mellitus
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
Diabetes Mellitus
A study of mRNA expression of glucose transporter gene in rats with diabetes mellitus.
Diabetes Mellitus
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
Diabetes Mellitus
An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.
Diabetes Mellitus
Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity.
Diabetes Mellitus
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Diabetes Mellitus
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
Diabetes Mellitus
Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals.
Diabetes Mellitus
Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.
Diabetes Mellitus
Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific.
Diabetes Mellitus
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Diabetes Mellitus
Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus.
Diabetes Mellitus
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Diabetes Mellitus
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
Diabetes Mellitus
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Diabetes Mellitus
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Diabetes Mellitus
Diabetes mellitus induces long lasting changes in the glucose transporter of rat heart endothelial cells.
Diabetes Mellitus
Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
Diabetes Mellitus
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Diabetes Mellitus
Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: A randomized controlled clinical trial.
Diabetes Mellitus
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24?weeks in patients with diabetes mellitus: A systematic review and meta-analysis.
Diabetes Mellitus
Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse.
Diabetes Mellitus
Exploring newer target sodium glucose transporter 2 for the treatment of diabetes mellitus.
Diabetes Mellitus
Expression of Glucose Transporter 4 (GLUT4) is Increased by Cinnamaldehyde in C2C12 Mouse Muscle Cells.
Diabetes Mellitus
Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes.
Diabetes Mellitus
Failure to detect Glut4-Ile383 and IR-Gln1152 variants in NIDDM (non-insulin dependent diabetes mellitus) and control subjects in an Italian population.
Diabetes Mellitus
Genetic polymorphisms at the human liver/islet glucose transporter (GLUT2) gene locus in Caucasian and West Indian subjects with type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Diabetes Mellitus
Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/drt) and viable yellow mouse (Avy/a).
Diabetes Mellitus
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
Diabetes Mellitus
GLUT3 glucose transporter isoform in rat testis: localization, effect of diabetes mellitus, and comparison to human testis.
Diabetes Mellitus
GLUT4 Gene Polymorphisms and Their Association with Type 2 Diabetes in South Indians.
Diabetes Mellitus
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Diabetes Mellitus
Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects.
Diabetes Mellitus
Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.
Diabetes Mellitus
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Diabetes Mellitus
Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model.
Diabetes Mellitus
Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line.
Diabetes Mellitus
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Diabetes Mellitus
Insulin-responsive glucose transporter expression in renal microvessels and glomeruli.
Diabetes Mellitus
Interleukin-18 (rs187238) and glucose transporter 4 (rs5435) polymorphisms in Euro-Brazilians with type 1 diabetes.
Diabetes Mellitus
Intestinal D-glucose transport and membrane fluidity along crypt-villus axis of streptozocin-induced diabetic rats.
Diabetes Mellitus
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Linkage analysis of the genetic markers of the candidate genes with non-insulin dependent diabetes mellitus in Chinese families.
Diabetes Mellitus
Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Diabetes Mellitus
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics.
Diabetes Mellitus
Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus.
Diabetes Mellitus
Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Pathological upregulation of inner blood-retinal barrier Glut1 glucose transporter expression in diabetes mellitus.
Diabetes Mellitus
Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Diabetes Mellitus
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
Diabetes Mellitus
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.
Diabetes Mellitus
Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus.
Diabetes Mellitus
Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.
Diabetes Mellitus
Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.
Diabetes Mellitus
Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes.
Diabetes Mellitus
Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Diabetes Mellitus
Type-2 diabetes down-regulates glucose transporter proteins and genes of the human blood leukocytes.
Diabetes Mellitus
Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice.
Diabetes Mellitus
[Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats]
Diabetes Mellitus, Experimental
Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus.
Diabetes Mellitus, Experimental
Blood-brain barrier glucose transporter mRNA is increased in experimental diabetes mellitus.
Diabetes Mellitus, Type 1
A C-peptide complex with albumin and Zn2+ increases measurable GLUT1 levels in membranes of human red blood cells.
Diabetes Mellitus, Type 1
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1 (GLUT1).
Diabetes Mellitus, Type 1
Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin-dependent diabetes mellitus of recent onset.
Diabetes Mellitus, Type 1
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Diabetes Mellitus, Type 1
Cinnamon extract enhances glucose uptake in 3T3-L1 adipocytes and C2C12 myocytes by inducing LKB1-AMP-activated protein kinase signaling.
Diabetes Mellitus, Type 1
Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
Diabetes Mellitus, Type 1
Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors.
Diabetes Mellitus, Type 1
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Diabetes Mellitus, Type 1
Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.
Diabetes Mellitus, Type 1
Interleukin-18 (rs187238) and glucose transporter 4 (rs5435) polymorphisms in Euro-Brazilians with type 1 diabetes.
Diabetes Mellitus, Type 1
Reduced beta-cell glucose transporter in new onset diabetic BB rats.
Diabetes Mellitus, Type 1
Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals.
Diabetes Mellitus, Type 1
Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
Diabetes Mellitus, Type 1
The effect of intensive insulin therapy on the insulin-regulatable glucose transporter (GLUT4) expression in skeletal muscle in type 1 diabetes.
Diabetes Mellitus, Type 2
(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice.
Diabetes Mellitus, Type 2
A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes.
Diabetes Mellitus, Type 2
A xanthene derivative, DS20060511, attenuates glucose intolerance by inducing skeletal muscle-specific GLUT4 translocation in mice.
Diabetes Mellitus, Type 2
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
Diabetes Mellitus, Type 2
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
Diabetes Mellitus, Type 2
Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes: The 2016 Banting Medal for Scientific Achievement Lecture.
Diabetes Mellitus, Type 2
Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Diabetes Mellitus, Type 2
Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage.
Diabetes Mellitus, Type 2
Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa).
Diabetes Mellitus, Type 2
An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.
Diabetes Mellitus, Type 2
Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Aqueous-Methanol Extracts of Orange-Fleshed Sweet Potato (Ipomoeabatatas) Ameliorate Oxidative Stress and Modulate Type 2 Diabetes Associated Genes in Insulin Resistant C2C12 Cells.
Diabetes Mellitus, Type 2
Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus, Type 2
Association between glucose transporter 1 rs841853 polymorphism and type 2 diabetes mellitus risk may be population specific.
Diabetes Mellitus, Type 2
Association between the membrane transporter proteins and type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Association of glucose transporter 1 polymorphisms with type 2 diabetes in the Tunisian population.
Diabetes Mellitus, Type 2
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes.
Diabetes Mellitus, Type 2
Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.
Diabetes Mellitus, Type 2
Associations between the HaeIII Single Nucleotide Polymorphism in the SLC2A1 Gene and Diabetic Nephropathy in Korean Patients with Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
BAG6 contributes to glucose uptake by supporting the cell surface translocation of the glucose transporter GLUT4.
Diabetes Mellitus, Type 2
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
Diabetes Mellitus, Type 2
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Diabetes Mellitus, Type 2
Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus.
Diabetes Mellitus, Type 2
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Diabetes Mellitus, Type 2
Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death.
Diabetes Mellitus, Type 2
Decreased expression of glucose transporter in muscle from insulin-resistant patients.
Diabetes Mellitus, Type 2
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay.
Diabetes Mellitus, Type 2
Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model.
Diabetes Mellitus, Type 2
Diabetes induces tri-methylation at lysine 9 of histone 3?at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control.
Diabetes Mellitus, Type 2
Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Diabetes Mellitus, Type 2
Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.
Diabetes Mellitus, Type 2
Duodenal sodium/glucose co-transporter 1 expression under fasting conditions is associated with post-load hyperglycemia.
Diabetes Mellitus, Type 2
Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats.
Diabetes Mellitus, Type 2
Effect of pomegranate seed oil supplementation on the GLUT-4 gene expression and glycemic control in obese people with type 2 diabetes: A randomized controlled clinical trial.
Diabetes Mellitus, Type 2
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24?weeks in patients with diabetes mellitus: A systematic review and meta-analysis.
Diabetes Mellitus, Type 2
Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.
Diabetes Mellitus, Type 2
Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse.
Diabetes Mellitus, Type 2
Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload.
Diabetes Mellitus, Type 2
Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns.
Diabetes Mellitus, Type 2
Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.
Diabetes Mellitus, Type 2
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.
Diabetes Mellitus, Type 2
Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.
Diabetes Mellitus, Type 2
Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle.
Diabetes Mellitus, Type 2
Exercise Increases Glucose Transporter-4 Levels on Peripheral Blood Mononuclear Cells.
Diabetes Mellitus, Type 2
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients.
Diabetes Mellitus, Type 2
Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion.
Diabetes Mellitus, Type 2
Failure to detect Glut4-Ile383 and IR-Gln1152 variants in NIDDM (non-insulin dependent diabetes mellitus) and control subjects in an Italian population.
Diabetes Mellitus, Type 2
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Diabetes Mellitus, Type 2
Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes.
Diabetes Mellitus, Type 2
Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM.
Diabetes Mellitus, Type 2
Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits.
Diabetes Mellitus, Type 2
Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF??B/GLUT?4.
Diabetes Mellitus, Type 2
Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Glucose transporter 4 gene: association studies pertaining to alleles of two polymorphisms in extremely obese children and adolescents and in normal and underweight controls.
Diabetes Mellitus, Type 2
Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.
Diabetes Mellitus, Type 2
Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non-Insulin-Dependent Diabetes.
Diabetes Mellitus, Type 2
GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population.
Diabetes Mellitus, Type 2
GLUT4 Gene Polymorphisms and Their Association with Type 2 Diabetes in South Indians.
Diabetes Mellitus, Type 2
Hep-G2 glucose transporter gene polymorphism in Caucasian, black, Hispanic and Japanese patients with NIDDM.
Diabetes Mellitus, Type 2
HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.
Diabetes Mellitus, Type 2
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Diabetes Mellitus, Type 2
Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors.
Diabetes Mellitus, Type 2
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Diabetes Mellitus, Type 2
Implications of the CANVAS Study in Reducing Cardiovascular Outcomes.
Diabetes Mellitus, Type 2
Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
Diabetes Mellitus, Type 2
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Diabetes Mellitus, Type 2
Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles.
Diabetes Mellitus, Type 2
Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Is it time to think about the sodium glucose co-transporter 2 sympathetically?
Diabetes Mellitus, Type 2
Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner.
Diabetes Mellitus, Type 2
Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2.
Diabetes Mellitus, Type 2
Linkage analysis of GLUT1 (HepG2) and GLUT2 (liver/islet) genes in familial NIDDM.
Diabetes Mellitus, Type 2
Linkage analysis of the genetic markers of the candidate genes with non-insulin dependent diabetes mellitus in Chinese families.
Diabetes Mellitus, Type 2
Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Diabetes Mellitus, Type 2
Mechanistic evaluation of the effect of sodium-dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics.
Diabetes Mellitus, Type 2
Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches.
Diabetes Mellitus, Type 2
Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects.
Diabetes Mellitus, Type 2
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.
Diabetes Mellitus, Type 2
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Diabetes Mellitus, Type 2
Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.
Diabetes Mellitus, Type 2
Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM.
Diabetes Mellitus, Type 2
Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM).
Diabetes Mellitus, Type 2
Polymorphisms at the GLUT2 (beta-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members.
Diabetes Mellitus, Type 2
Post-GLUT-2 defects in beta-cells of non-insulin-dependent diabetic obese rats.
Diabetes Mellitus, Type 2
Preservation of GLUT 2 expression in islet beta cells of Kilham rat virus (KRV)-infected diabetes-resistant BB/Wor rats.
Diabetes Mellitus, Type 2
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Diabetes Mellitus, Type 2
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle.
Diabetes Mellitus, Type 2
Rapid and simultaneous detection of multiple mutations by pooled and multiplex single nucleotide primer extension: application to the study of insulin-responsive glucose transporter and insulin receptor mutations in non-insulin-dependent diabetes.
Diabetes Mellitus, Type 2
Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
Diabetes Mellitus, Type 2
Regulation of glucose transport by pioglitazone in cultured muscle cells.
Diabetes Mellitus, Type 2
Relationship between muscle fibre composition, glucose transporter protein 4 and exercise training: possible consequences in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Resistance training is medicine: effects of strength training on health.
Diabetes Mellitus, Type 2
Restriction site polymorphisms at the human HepG2 glucose transporter gene locus in Caucasian and west Indian subjects with non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Risk stratification tools for heart failure in the diabetes clinic.
Diabetes Mellitus, Type 2
Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.
Diabetes Mellitus, Type 2
Sequence variations of the pancreatic islet/liver glucose transporter (GLUT2) gene in Japanese subjects with noninsulin dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes.
Diabetes Mellitus, Type 2
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Diabetes Mellitus, Type 2
Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells.
Diabetes Mellitus, Type 2
Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young.
Diabetes Mellitus, Type 2
Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.
Diabetes Mellitus, Type 2
Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes.
Diabetes Mellitus, Type 2
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: Impact of the 2020 KDIGO clinical practice guidelines.
Diabetes Mellitus, Type 2
Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes.
Diabetes Mellitus, Type 2
Structure and mechanism of the mammalian fructose transporter GLUT5.
Diabetes Mellitus, Type 2
Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells.
Diabetes Mellitus, Type 2
The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation.
Diabetes Mellitus, Type 2
The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.
Diabetes Mellitus, Type 2
The different hypoglycemic effects between East Asian and non-Asian type 2 diabetes patients when treated with SGLT-2 inhibitors as an add-on treatment for metformin: a systematic review and meta-analysis of randomized controlled trials.
Diabetes Mellitus, Type 2
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy.
Diabetes Mellitus, Type 2
Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice.
Diabetes Mellitus, Type 2
Use of DNA polymorphisms for genetic analysis of non-insulin dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients.
Diabetes Mellitus, Type 2
WNK1 kinase is essential for insulin-stimulated GLUT4 trafficking in skeletal muscle.
Diabetes Mellitus, Type 2
[Candidate gene approach in Japanese NIDDM: liver/pancreatic beta cell type glucose transporter (GLUT2)]
Diabetes Mellitus, Type 2
[Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium]
Diabetes Mellitus, Type 2
[Effects of Chinese herbal medicine Yiqi Zengmin formula on expression of glucose transporter 4 in skeletal muscle in type 2 diabetic rats].
Diabetes Mellitus, Type 2
[Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats]
Diabetes Mellitus, Type 2
[Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus]
Diabetes Mellitus, Type 2
[The CHC22 human clathrin heavy chain isoform, intracellular traffic of the glucose transporter GLUT4, and type 2 diabetes]
Diabetes Mellitus, Type 2
[The detection of GLUT2 gene mutation by polymerase-chain reaction single stranded conformation polymorphism (PCR-SSCP) method]
Diabetes, Gestational
Decreased expression of the GLUT4 glucose transporter protein in adipose tissue during pregnancy.
Diabetes, Gestational
Expression and correlation of sex hormone-binding globulin and insulin signal transduction and glucose transporter proteins in gestational diabetes mellitus placental tissue.
Diabetes, Gestational
Fine particulate matter (PM2.5), a risk factor of rat gestational diabetes with altered blood glucose and pancreatic GLUT2 expression.
Diabetes, Gestational
Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight.
Diabetes, Gestational
High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway.
Diabetes, Gestational
The Effect of Zinc Supplementation on Expressed Levels of Peroxisome Proliferator-Activated Receptor Gamma and Glucose Transporter Type 1 Genes in Newborns of Women with Gestational Diabetes Mellitus.
Diabetes, Gestational
Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Diabetic Cardiomyopathies
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Diabetic Cardiomyopathies
Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.
Diabetic Cardiomyopathies
Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal-jejunal bypass.
Diabetic Ketoacidosis
A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
Diabetic Ketoacidosis
Corrigendum to A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
Diabetic Ketoacidosis
Sodium Glucose Transporter 2 Inhibitors and Diabetic Ketoacidosis in Three Patients with Diabetes: Underlying Causation.
Diabetic Nephropathies
A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus.
Diabetic Nephropathies
Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene.
Diabetic Nephropathies
Association of HaeIII single nucleotide polymorphisms in the SLC2A1 gene with risk of diabetic nephropathy; Evidence from Kurdish patients with type 2 diabetes mellitus.
Diabetic Nephropathies
Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.
Diabetic Nephropathies
Changes in Renal Glucose Transporters in an Animal Model of Metabolic Syndrome.
Diabetic Nephropathies
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.
Diabetic Nephropathies
Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients.
Diabetic Nephropathies
GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy.
Diabetic Nephropathies
Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1alpha.
Diabetic Nephropathies
Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
Diabetic Nephropathies
Marein ameliorates diabetic nephropathy by inhibiting renal sodium glucose transporter 2 and activating the AMPK signaling pathway in db/db mice and high glucose-treated HK-2 cells.
Diabetic Nephropathies
Podocyte Specific Overexpression of GLUT1 Surprisingly Reduces Mesangial Matrix Expansion in Diabetic Nephropathy in Mice.
Diabetic Nephropathies
Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Diabetic Nephropathies
Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy.
Diabetic Nephropathies
Prompt apoptotic response to high glucose in SGLT-expressing renal cells.
Diabetic Nephropathies
Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.
Diabetic Nephropathies
Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats.
Diabetic Nephropathies
Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.
Diabetic Nephropathies
Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.
Diabetic Nephropathies
Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease.
Diabetic Nephropathies
XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy.
Diabetic Retinopathy
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Diabetic Retinopathy
GLUT1 activity contributes to the impairment of PEDF secretion by the RPE.
Diabetic Retinopathy
Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal pericytes.
Diffuse Cerebral Sclerosis of Schilder
Metabolic epilepsies: approaches to a diagnostic challenge.
DiGeorge Syndrome
Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
Drug Resistant Epilepsy
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
Drug Resistant Epilepsy
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Drug Resistant Epilepsy
Perioperative Management of a Child With Glucose Transporter Type 1 Deficiency Syndrome: A Case Report.
Drug Resistant Epilepsy
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.
Dyskinesias
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Dyskinesias
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Dyskinesias
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Dyskinesias
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Dyskinesias
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
Dyskinesias
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Dyslipidemias
Effects of neonatal dexamethasone administration on cardiac recovery ability under ischemia-reperfusion in 24 weeks old rats.
Dystonia
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Dystonic Disorders
The benefits of a Neurogenetics clinic in an adult Academic Teaching Hospital.
Ecchymosis
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Encephalitis
Dysregulation of sonic hedgehog pathway and pericytes in the brain after lentiviral infection.
Encephalomyelitis
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Encephalomyelitis, Autoimmune, Experimental
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Endometrial Hyperplasia
Immunohistochemical investigation of metabolic markers fatty acid synthase (FASN) and glucose transporter 1 (GLUT1) in normal endometrium, endometrial hyperplasia, and endometrial malignancy.
Endometrial Neoplasms
Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells.
Endometrial Neoplasms
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
Endometrial Neoplasms
GLUT 1 expression is a supportive mean in predicting prognosis and survival estimates of endometrial carcinoma.
Endometrial Neoplasms
LEFTY2/endometrial bleeding-associated factor up-regulates Na+ Coupled Glucose Transporter SGLT1 expression and Glycogen Accumulation in Endometrial Cancer Cells.
Endometrial Neoplasms
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Endometrial Neoplasms
The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.
Endometrial Neoplasms
The NF-?B signalling pathway regulates GLUT6 expression in endometrial cancer.
Endometriosis
Understanding the Role of Gui-Zhi-Fu-Ling-Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics.
Endotoxemia
Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells.
Endotoxemia
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
Eosinophilia
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation.
Epilepsies, Myoclonic
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy.
Epilepsies, Myoclonic
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Epilepsies, Myoclonic
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Epilepsies, Partial
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Epilepsy
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Epilepsy
A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain.
Epilepsy
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Epilepsy
Acetazolamide-responsive Episodic Ataxia Without Baseline Deficits or Seizures Secondary to GLUT1 Deficiency: A Case Report and Review of the Literature.
Epilepsy
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Epilepsy
Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy.
Epilepsy
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Epilepsy
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Epilepsy
Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.
Epilepsy
Glucose Transporter 1 Deficiency as a Treatable Cause of Myoclonic Astatic Epilepsy.
Epilepsy
Glucose transporter type 1 deficiency due to SLC2A1 gene mutations--a rare but treatable cause of metabolic epilepsy and extrapyramidal movement disorder; own experience and literature review.
Epilepsy
Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy.
Epilepsy
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Epilepsy
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
Epilepsy
Impact of the Ketogenic Diet on Linear Growth in Children: A Single-Center Retrospective Analysis of 34 Cases.
Epilepsy
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Epilepsy
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
Epilepsy
NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.
Epilepsy
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
Epilepsy
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Epilepsy
Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study.
Epilepsy
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
Epilepsy
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
Epilepsy
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Epilepsy
Use of Remote Monitoring by E-mail for Long-Term Management of the Classic Ketogenic Diet.
Epilepsy
Variants in KCNJ11 and BAD do not predict response to ketogenic dietary therapies for epilepsy.
Epilepsy
[Experience of using ketogenic diet in a patient with glucose transporter 1 deficiency syndrome (a case report)].
Epilepsy
[Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome]
Epilepsy, Absence
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Epilepsy, Absence
Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1.
Epilepsy, Absence
Intermittent Ataxia with Early Onset Absence Epilepsy in Glucose Transporter Type 1 Deficiency Syndrome.
Epilepsy, Absence
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
Epilepsy, Absence
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Epilepsy, Generalized
Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency.
Epilepsy, Generalized
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Epilepsy, Generalized
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
Epilepsy, Generalized
Glucose transporter 1 deficiency in the idiopathic generalized epilepsies.
Epilepsy, Generalized
Glut-1 deficiency syndrome masquerading as idiopathic generalized epilepsy.
Epilepsy, Generalized
Investigation of SLC2A1 gene variants in genetic generalized epilepsy patients with eyelid myoclonia.
Epileptic Syndromes
Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
Esophageal Neoplasms
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Esophageal Neoplasms
Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.
Esophageal Squamous Cell Carcinoma
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Esophageal Squamous Cell Carcinoma
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
Esophageal Squamous Cell Carcinoma
Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Essential Hypertension
Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis.
Fanconi Syndrome
A Fanconi-Bickel syndrome patient with a novel mutation and accompanying situs inversus totalis.
Fanconi Syndrome
A novel mutation of the GLUT2 gene in a Turkish patient with Fanconi-Bickel syndrome.
Fanconi Syndrome
Acute metabolic acidosis in a GLUT2-deficient patient with Fanconi-Bickel syndrome: new pathophysiology insights.
Fanconi Syndrome
An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene.
Fanconi Syndrome
Fanconi Bickel syndrome: clinical phenotypes and genetics in a cohort of Sudanese children.
Fanconi Syndrome
Fanconi Bickel Syndrome: Novel Mutations in GLUT 2 Gene Causing a Distinguished Form of Renal Tubular Acidosis in Two Unrelated Egyptian Families.
Fanconi Syndrome
Fanconi syndrome and neonatal diabetes: phenotypic heterogeneity in patients with GLUT2 defects.
Fanconi Syndrome
Fanconi-Bickel Syndrome and Autosomal Recessive Proximal Tubulopathy with Hypercalciuria (ARPTH) Are Allelic Variants Caused by GLUT2 Mutations.
Fanconi Syndrome
Fanconi-Bickel syndrome in an infant with cytomegalovirus infection: A case report and review of the literature.
Fanconi Syndrome
Fanconi-Bickel syndrome in two Palestinian children: marked phenotypic variability with identical mutation.
Fanconi Syndrome
Fanconi-Bickel syndrome versus osteogenesis imperfeeta: An Iranian case with a novel mutation in glucose transporter 2 gene, and review of literature.
Fanconi Syndrome
Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature.
Fanconi Syndrome
Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype.
Fanconi Syndrome
Genetic testing of two Pakistani patients affected with rare autosomal recessive Fanconi-Bickel syndrome and identification of a novel SLC2A2 splice site variant.
Fanconi Syndrome
Impaired glucose tolerance in Fanconi-Bickel syndrome: Eight patients with two novel mutations.
Fanconi Syndrome
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Fanconi Syndrome
Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome.
Fanconi Syndrome
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Fanconi Syndrome
The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome.
Fanconi Syndrome
Two cases of Fanconi-Bickel syndrome: first report from China with novel mutations of SLC2A2 gene.
Fatty Liver
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.
Fetal Diseases
Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy.
Fetal Growth Retardation
Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction.
Fetal Growth Retardation
Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation.
Fetal Growth Retardation
Humanin (HN) and glucose transporter 8 (GLUT8) in pregnancies complicated by intrauterine growth restriction.
Fetal Growth Retardation
IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? -- a review.
Fetal Growth Retardation
Insight Into the Pathogenesis of Fetal Growth Restriction in Placental Malaria: Decreased Placental Glucose Transporter Isoform 1 Expression.
Fetal Growth Retardation
Intra-uterine growth restriction differentially regulates perinatal brain and skeletal muscle glucose transporters.
Fetal Growth Retardation
Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression.
Fetal Growth Retardation
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression1.
Fetal Growth Retardation
Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles.
Fetal Growth Retardation
Placental expression of glucose transporter proteins 1 and 3 in growth-restricted fetal rats.
Fetal Growth Retardation
Placental glucose transporter 1 and 3 gene expression in Monochorionic twin pregnancies with selective fetal growth restriction.
Fetal Growth Retardation
Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.
Fetal Growth Retardation
Placental transporter activity and expression in relation to fetal growth.
Fetal Growth Retardation
Placental-Specific Overexpression of sFlt-1 Alters Trophoblast Differentiation and Nutrient Transporter Expression in an IUGR Mouse Model.
Fetal Growth Retardation
The effect of intrauterine growth restriction upon fetal and postnatal hepatic glucose transporter and glucokinase proteins.
Fetal Growth Retardation
The relationship between fetal growth restriction and small placenta in 6-mercaptopurine exposed rat.
Fetal Growth Retardation
The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle.
Fibrosarcoma
Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction.
Fibrosarcoma
High-fat diet induced insulin resistance in pregnant rats through pancreatic pax6 signaling pathway.
Fibrosarcoma
Insulin-Deficient Mouse ?-Cells Do Not Fully Maturebut Can Be Remedied Through Insulin Replacementby Islet Transplantation.
Fibrosarcoma
Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic ?-cell proliferation in type 2 diabetic mice.
Fibrosarcoma
[?-aminobutyric acid fortified rice alleviated oxidative stress and pancreatic injury in type 2 diabetic mice].
Gastrointestinal Neoplasms
Insulin resistance and tissue glycogen content in the tumor-bearing state.
Gastrointestinal Neoplasms
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Gastrointestinal Stromal Tumors
ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression.
Genetic Diseases, Inborn
From splitting GLUT1 deficiency syndromes to overlapping phenotypes.
Genetic Diseases, Inborn
Glut1 deficiency is a rare but treatable cause of childhood absence epilepsy with atypical features.
Genetic Diseases, Inborn
Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
Glioblastoma
Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.
Glioblastoma
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
Glioblastoma
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.
Glioblastoma
Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-?.
Glioblastoma
Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.
Glioblastoma
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
Glioma
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
Glioma
Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia.
Glioma
Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
Glioma
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Glioma
Glucose transporter Glut1 controls diffuse invasion phenotype with perineuronal satellitosis in diffuse glioma microenvironment.
Glioma
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
Glioma
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.
Glioma
Liposomes actively recognizing the glucose transporter GLUT1 and integrin ?v ?3 for dual-targeting of glioma.
Glioma
miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
Glioma
N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.
Glioma
Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Glioma
Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1?.
Glioma
Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes.
Glioma
Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft.
Glioma
Specific protein 1 depletion attenuates glucose uptake and proliferation of human glioma cells by regulating GLUT3 expression.
Glioma
Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids.
glucan 1,4-alpha-glucosidase deficiency
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Glucose Intolerance
A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro.
Glucose Intolerance
Acute high-fat feeding leads to disruptions in glucose homeostasis and worsens stroke outcome.
Glucose Intolerance
Altered expression of glucose transporter isoforms with aging in rats--selective decrease in GluT4 in the fat tissue and skeletal muscle.
Glucose Intolerance
Binding forces of hepatic microsomal and plasma membrane proteins in normal and pancreatitic rats: an AFM force spectroscopic study.
Glucose Intolerance
Defective insulin-stimulated GLUT4 translocation in brown adipocytes induces systemic glucose homeostasis dysregulation independent of thermogenesis in female mice.
Glucose Intolerance
Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance.
Glucose Intolerance
Fermented tea improves glucose intolerance in mice by enhancing translocation of glucose transporter 4 in skeletal muscle.
Glucose Intolerance
Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice.
Glucose Intolerance
Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4.
Glucose Intolerance
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
Glucose Intolerance
High-fat diet affects pregestational adiposity and glucose tolerance perturbing gestational placental macronutrient transporters culminating in an obese offspring in wild-type and glucose transporter isoform 3 heterozygous null mice.
Glucose Intolerance
HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Glucose Intolerance
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization.
Glucose Intolerance
Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity.
Glucose Intolerance
Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice.
Glucose Intolerance
MicroRNA?106b regulates skeletal muscle insulin sensitivity and glucose homeostasis by targeting mitofusion?2.
Glucose Intolerance
Molecular approach to identify antidiabetic potential of Azadirachta indica.
Glucose Intolerance
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Glucose Intolerance
Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice.
Glucose Intolerance
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Glucose Intolerance
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
Glucose Intolerance
Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM.
Glucose Intolerance
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth.
Glycogen Storage Disease
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Glycogen Storage Disease
[Fanconi-Bickel-Syndrom: a novel genetic disease in Original Braunvieh].
Glycogen Storage Disease Type II
Effect of acid maltase deficiency on the endosomal/lysosomal system and glucose transporter 4.
Glycogen Storage Disease Type IIb
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Glycosuria
Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
Glycosuria
Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk.
Glycosuria
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.
Glycosuria
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
Glycosuria
Syzygium jambos extract mitigates pancreatic oxidative stress, inflammation and apoptosis and modulates hepatic IRS-2/AKT/GLUT4 signaling pathway in streptozotocin-induced diabetic rats.
Granuloma
Multifocal congenital pyogenic granuloma successfully treated with oral propranolol.
Head and Neck Neoplasms
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1? expression, tumor invasiveness, and patient prognosis.
Head and Neck Neoplasms
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin.
Heart Defects, Congenital
Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.
Heart Diseases
Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers.
Heart Diseases
Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?
Heart Failure
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Heart Failure
Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.
Heart Failure
Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload.
Heart Failure
Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy.
Heart Failure
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
Heart Failure
Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart.
Heart Failure
[Effects of neregulin on rhesus monkey heart failure induced by rapid pacing]
Hemangioblastoma
Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3'-untranslated region of the human glucose transporter 1 (GLUT1) messenger RNA.
Hemangioblastoma
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
Hemangioma
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.
Hemangioma
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
Hemangioma
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Hemangioma
Human monocyte-derived hemangioma-like endothelial cells: evidence from an in vitro study.
Hemangioma
Immunoreactivity of Wilms tumor 1 (WT1) as an additional evidence supporting hemangiomatous rather than inflammatory origin in the etiopathogenesis of angiolymphoid hyperplasia with eosinophilia.
Hemangioma
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.
Hemangioma
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
Hemangioma
Multifocal congenital pyogenic granuloma successfully treated with oral propranolol.
Hemangioma
The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children.
Hemangioma
Vascular Lesions: GLUT-1 Expression as a Diagnostic Tool to Discriminate Tumors From Malformations.
Hemangioma
[Posterior mediastinum infantile hemangioma in an 11 months infant, an unusual finding. A case report and review of the literature].
Hemangioma
[Sinusoidal hemangioma: Immunohistochemical analysis with glucose transporter 1 (GLUT1) and williams tumor protein 1 (WT1)]
Hemangioma
[The impact of Glut-1 marker application on the diagnosis and treatment of congenital vascular anomalies]
Hemangioma, Capillary
Capillary hemangioma of the central nervous system: a comparative study with lobular capillary hemangioma of the skin.
Hemangioma, Capillary
Glucose transporter isoform-1 receptor-positive infantile capillary hemangiomas: case report and literature review.
Hemiplegia
Lack of SLC2A1 (Glucose Transporter 1) Mutations in 30 Italian Patients With Alternating Hemiplegia of Childhood.
Hepatitis B
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host.
Hepatolenticular Degeneration
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Hepatolenticular Degeneration
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Hepatomegaly
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Herpes Simplex
A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin.
Herpes Simplex
Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.
Herpes Simplex
An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid.
Herpes Simplex
Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults.
Herpes Simplex
Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.
Herpes Simplex
Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.
Herpes Simplex
Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.
Herpes Zoster
Dysregulation of sonic hedgehog pathway and pericytes in the brain after lentiviral infection.
Herpes Zoster
Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region.
Herpes Zoster
Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus.
Histiocytoma
An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms.
HIV Infections
Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression.
HIV Infections
Increased uptake and accumulation of vitamin C in human immunodeficiency virus 1-infected hematopoietic cell lines.
Hodgkin Disease
Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
Homocystinuria
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Huntington Disease
Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.
Huntington Disease
The glucose transporter (GLUT4) enhancer factor is required for normal wing positioning in Drosophila.
Huntington Disease
Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
Hyperandrogenism
Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome.
Hyperandrogenism
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Hyperglycemia
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
Hyperglycemia
A Journey to Understand Glucose Homeostasis: Starting from Rat Glucose Transporter Type 2 Promoter Cloning to Hyperglycemia.
Hyperglycemia
Activation of PERK-eIF2?-ATF4 pathway contributes to diabetic hepatotoxicity: Attenuation of ER stress by Morin.
Hyperglycemia
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Hyperglycemia
Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Hyperglycemia
Antihyperglycemic and antioxidative effects of new herbal formula in streptozotocin-induced diabetic rats.
Hyperglycemia
Antioxidant effect of myricitrin on hyperglycemia-induced oxidative stress in C2C12 cell.
Hyperglycemia
Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats.
Hyperglycemia
Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
Hyperglycemia
Brain uptake of glucose in diabetes mellitus: the role of glucose transporters.
Hyperglycemia
Changes in Expression of Follicular Glucose Transporters May Be Involved in Ovarian Function Impairment during Diabetic Hyperglycemia.
Hyperglycemia
Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.
Hyperglycemia
Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells.
Hyperglycemia
Effect of streptozotocin-induced maternal diabetes on fetal rat brain glucose transporters.
Hyperglycemia
Gene expression of epithelial glucose transporters: the role of diabetes mellitus.
Hyperglycemia
Glucose rapidly decreases plasma membrane GLUT4 content in rat skeletal muscle.
Hyperglycemia
Glucose regulation of glucose transporters in cultured adult and fetal hepatocytes.
Hyperglycemia
Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia.
Hyperglycemia
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
Hyperglycemia
Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy.
Hyperglycemia
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Hyperglycemia
Glucose transporters: cellular links to hyperglycemia in insulin resistance and diabetes.
Hyperglycemia
Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat.
Hyperglycemia
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
Hyperglycemia
Green Tea Ameliorates Hyperglycemia by Promoting the Translocation of Glucose Transporter 4 in the Skeletal Muscle of Diabetic Rodents.
Hyperglycemia
High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice.
Hyperglycemia
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Hyperglycemia
Hyperglycemia is associated with poor survival in primary central nervous system lymphoma patients.
Hyperglycemia
Hyperglycemia Reduces Mitochondrial Content and Glucose Transporter Expression in Mouse Embryos Developing In Vitro.
Hyperglycemia
Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain.
Hyperglycemia
Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake.
Hyperglycemia
Intrauterine hyperglycemia increases insulin binding sites but not glucose transporter expression in discrete brain areas in term rat fetuses.
Hyperglycemia
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Hyperglycemia
Mechanisms of Congenital Malformations in Pregnancies with Pre-existing Diabetes.
Hyperglycemia
Molecular cloning of glucose transporter 1 in grouper Epinephelus coioides and effects of an acute hyperglycemia stress on its expression and glucose tolerance.
Hyperglycemia
N-Hydroxycinnamide Derivatives of Osthole Ameliorate Hyperglycemia through Activation of AMPK and p38 MAPK.
Hyperglycemia
Piperlongumine attenuates oxidative stress, inflammatory, and apoptosis through modulating the GLUT-2/4 and AKT signaling pathway in streptozotocin-induced diabetic rats.
Hyperglycemia
Reactive oxygen species downregulate glucose transport system in retinal endothelial cells.
Hyperglycemia
Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models.
Hyperglycemia
Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta cells of diabetic rats.
Hyperglycemia
Resistance training restores metabolic alterations induced by monosodium glutamate in a sex-dependent manner in male and female rats.
Hyperglycemia
Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
Hyperglycemia
Role of liver-type glucose transporter (GLUT2) in transport across the basolateral membrane in rat jejunum.
Hyperglycemia
Short-term mild hyperglycemia enhances insulin-stimulated glucose disposal in lactating goats.
Hyperglycemia
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Hyperglycemia
T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
Hyperglycemia
The cacao procyanidin extract-caused anti-hyperglycemic effect was changed by the administration timings.
Hyperglycemia
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Hyperglycemia
The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner.
Hyperglycemia
The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.
Hyperglycemia
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Hyperglycemia
Time-dependent and tissue-specific effects of circulating glucose on fetal ovine glucose transporters.
Hyperglycemia
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein.
Hyperglycemia
Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.
Hyperglycemia
Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
Hyperglycemia
Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle.
Hyperglycemia
Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes.
Hyperglycemia
[Effect of glimepiride on the glucose uptake of rat mandibular osteoblasts in hyperglycemia].
Hyperglycemia
[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].
Hyperglycinemia, Nonketotic
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Hyperglycinemia, Nonketotic
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Hyperinsulinism
Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
Hyperinsulinism
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
Hyperinsulinism
GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance.
Hyperinsulinism
Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor.
Hyperinsulinism
Impact of insulin and glucocorticoid signalling on hepatic glucose homeostasis in the rat exposed to high-fructose diet and chronic stress.
Hyperinsulinism
In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues.
Hyperinsulinism
Intrauterine hyperglycemia increases insulin binding sites but not glucose transporter expression in discrete brain areas in term rat fetuses.
Hyperinsulinism
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Hyperinsulinism
Putative Involvement of Endocrine Disruptors in the Alzheimer's disease Via the Insulin-Regulated Aminopeptidase / GLUT4 Pathway.
Hyperinsulinism
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Hyperinsulinism
Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
Hyperlipidemias
(-)-Epicatechin-3-O-?-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.
Hyperlipidemias
Acute hypoxic preconditioning prevents palmitic acid-induced cardiomyocyte apoptosis via switching metabolic GLUT4-glucose pathway back to CD36-fatty acid dependent.
Hyperlipidemias
Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
Hyperlipidemias
Ergostatrien-3?-ol from Antrodia camphorata Inhibits Diabetes and Hyperlipidemia in High-Fat-Diet Treated Mice via Regulation of Hepatic Related Genes, Glucose Transporter 4, and AMP-Activated Protein Kinase Phosphorylation.
Hyperlipidemias
Feeding a slowly digestible carbohydrate diet during pregnancy of insulin-resistant rats prevents the excess of adipogenesis in their offspring.
Hyperlipidemias
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Hyperlipidemias
Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation.
Hyperparathyroidism
3-Hydroxybutyrate administration elevates plasma parathyroid hormone in a pilot human randomized, controlled, cross over trial.
Hypertension
Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.
Hypertension
Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4.
Hypertension, Pulmonary
Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
Hyperthyroidism
Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.
Hyperthyroidism
Age-related changes in thyroid hormone effects on glucose transporter isoforms of rat heart.
Hyperthyroidism
Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray.
Hyperthyroidism
IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism.
Hyperthyroidism
Increased glucose transporter (GLUT4) protein expression in hyperthyroidism.
Hyperthyroidism
Quantity of Na/K-ATPase and glucose transporters in the plasma membrane of rat adipocytes is reduced by in vivo triiodothyronine.
Hyperthyroidism
Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface.
Hyperthyroidism
Thyroid hormone-induced GLUT-1 expression in rat cerebral tissue: effect of age.
Hypertrophy, Left Ventricular
The Effects of Pycnogenol® as Add-on Drug to Metformin Therapy in Diabetic Rats.
Hypoglycemia
An insulin-like growth factor II-producing histiocytoma associated with hypoglycemia: analysis of the peptide, its gene expression, and glucose transporter isoforms.
Hypoglycemia
Changes in muscle mRNAs for hexokinase, phosphofructokinase-1 and glycogen synthase in acute and persistent hypoglycemia induced by tolbutamide in chickens.
Hypoglycemia
Effects of caudal fourth ventricular lactate infusion on hypoglycemia-associated MCT2, GLUT3, GLUT4, GCK, and sulfonylurea receptor-1 gene expression in the ovariectomized female rat LHA and VMH: impact of estradiol.
Hypoglycemia
Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization.
Hypoglycemia
Glucose transport in brain and retina: implications in the management and complications of diabetes.
Hypoglycemia
Glucose transporter 2 mediates the hypoglycemia-induced increase in cerebral blood flow.
Hypoglycemia
Glucose transporter gene expression in rat brain: Pretranslational changes associated with chronic insulin-induced hypoglycemia, fasting, and diabetes.
Hypoglycemia
Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation.
Hypoglycemia
Glucose transporters (GLUT1, 2, & 4) in fat, muscle and liver in a rat model of endotoxic shock.
Hypoglycemia
Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
Hypoglycemia
Hypoglycemia induced changes in cholinergic receptor expression in the cerebellum of diabetic rats.
Hypoglycemia
Increase in glucose transporter densities of Glut3 and decrease of glucose utilization in rat brain after one week of hypoglycemia.
Hypoglycemia
Insulin-induced hypoglycemia associations with gene expression changes in liver and hypothalamus of chickens from lines selected for low or high body weight.
Hypoglycemia
Low glucose enhances Na+/glucose transport in bovine brain artery endothelial cells.
Hypoglycemia
Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression.
Hypoglycemia
Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression1.
Hypoglycemia
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Hypoglycemia
Quantity of glucose transporter and appetite-associated factor mRNA in various tissues after insulin injection in chickens selected for low or high body weight.
Hypoglycemia
Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes.
Hypoglycemia
Testicular regulation of neuronal glucose and monocarboxylate transporter gene expression profiles in CNS metabolic sensing sites during acute and recurrent insulin-induced hypoglycemia.
Hypoglycemia
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus.
Hypoglycemia
Time-dependent and tissue-specific effects of circulating glucose on fetal ovine glucose transporters.
Hypoglycemia
Time-dependent physiological regulation of ovine placental GLUT-3 glucose transporter protein.
Hypoglycemia
Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.
Hypoglycemia
Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia.
Hypopharyngeal Neoplasms
Role of GLUT-1 in the Upregulation of PD-L1 Expression After Radiotherapy and Association of PD-L1 with Favourable Overall Survival in Hypopharyngeal Cancer.
Hypophosphatemia
Fanconi-Bickel Syndrome and Autosomal Recessive Proximal Tubulopathy with Hypercalciuria (ARPTH) Are Allelic Variants Caused by GLUT2 Mutations.
Hypothyroidism
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Hypothyroidism
Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.
Hypothyroidism
The Possible Mechanisms of the Impaired Insulin Secretion in Hypothyroid Rats.
Hypothyroidism
Thyroid Deficiency Before Birth Alters the Adipose Transcriptome to Promote Overgrowth of White Adipose Tissue and Impair Thermogenic Capacity.
Hypoxia-Ischemia, Brain
Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain.
Hypoxia-Ischemia, Brain
Circulating blood cellular glucose transporters - Surrogate biomarkers for neonatal hypoxic-ischemic encephalopathy assessed by novel scoring systems.
Ileitis
Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na+/H+ exchanger 3 in SAMP1/Fc mice.
Infarction, Middle Cerebral Artery
Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
Infarction, Middle Cerebral Artery
Ischemic injury induces brain glucose transporter gene expression.
Infarction, Middle Cerebral Artery
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Infections
A study of the role of glucose transporter 1 (Glut1) in white spot syndrome virus (WSSV) infection.
Infections
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Infections
Campylobacter jejuni influences the expression of nutrient transporter genes in the intestine of chickens.
Infections
Cryptosporidium parvum alters glucose transport mechanisms in infected enterocytes.
Infections
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
Infections
Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells.
Infections
Glucose transporter GLUT1 influences Plasmodium berghei infection in Anopheles stephensi.
Infections
Glucose uptake and adenoviral mediated GLUT1 infection decrease hypoxia-induced HIF-1alpha levels in cardiac myocytes.
Infections
Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection.
Infections
Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.
Infections
Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression.
Infections
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Infections
Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection.
Infections
Immunohistochemical Study of Glucose Transporter GLUT-5 in Duodenal Epithelium in Norm and in T-2 Mycotoxicosis.
Infections
In Vitro Infection of Trypanosoma cruzi Causes Decrease in Glucose Transporter Protein-1 (GLUT1) Expression in Explants of Human Placental Villi Cultured under Normal and High Glucose Concentrations.
Infections
Increased uptake and accumulation of vitamin C in human immunodeficiency virus 1-infected hematopoietic cell lines.
Infections
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Infections
Insulin-stimulated translocation of the HepG2/erythrocyte-type glucose transporter expressed in 3T3-L1 adipocytes.
Infections
Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.
Infections
Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity.
Infections
Reduction of Mosquito Survival in Mice Vaccinated with Anopheles stephensi Glucose Transporter.
Infections
Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Infections
Systematic genetic dissection of PTS in Vibrio cholerae uncovers a novel glucose transporter and a limited role for PTS during infection of a mammalian host.
Infections
The central metabolism regulator EIIAGlc switches Salmonella from growth arrest to acute virulence through activation of virulence factor secretion.
Infections
The GhSWEET42 Glucose Transporter Participates in Verticillium dahliae Infection in Cotton.
Infections
The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Infections
Transport processes of 2-deoxy-D-glucose in erythrocytes infected with Plasmodium yoelii, a rodent malaria parasite.
Infections
Vibrio parahaemolyticus infection impaired intestinal barrier function and nutrient absorption in Litopenaeus vannamei.
Insulin Resistance
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
Insulin Resistance
A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats.
Insulin Resistance
A high fat diet impairs stimulation of glucose transport in muscle. Functional evaluation of potential mechanisms.
Insulin Resistance
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
Insulin Resistance
A mixture of apple pomace and rosemary extract improves fructose consumption-induced insulin resistance in rats: modulation of sarcolemmal CD36 and glucose transporter-4.
Insulin Resistance
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Insulin Resistance
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction.
Insulin Resistance
Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.
Insulin Resistance
ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.
Insulin Resistance
Activated central galanin type 1 receptor alleviated insulin resistance in diabetic rat muscle.
Insulin Resistance
Activation of central galanin receptor 2 mitigated insulin resistance in adipocytes of diabetic rats.
Insulin Resistance
Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.
Insulin Resistance
Activiated galanin receptor 2 attenuates insulin resistance in skeletal muscle of obese mice.
Insulin Resistance
ADP-ribosylation factor 6 regulates endothelin-1-induced lipolysis in adipocytes.
Insulin Resistance
Age-dependent impairment of adipose-derived stem cells isolated from horses.
Insulin Resistance
Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice.
Insulin Resistance
alpha2 Isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-d-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Insulin Resistance
Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
Insulin Resistance
Altered Central Nutrient Sensing in Male Mice Lacking Insulin Receptors in Glut4-Expressing Neurons.
Insulin Resistance
Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome.
Insulin Resistance
Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: protein in muscle from patients with acanthosis nigricans and severe insulin resistance.
Insulin Resistance
Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter.
Insulin Resistance
An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPAR{gamma}, adipogenesis, and insulin-responsive hexose transport.
Insulin Resistance
Analysis of amino and carboxy terminal GLUT-4 targeting motifs in 3T3-L1 adipocytes using an endosomal ablation technique.
Insulin Resistance
Analysis of candidate genes for insulin resistance in essential hypertension.
Insulin Resistance
Anti-diabetic effects of a coptis chinensis containing new traditional chinese medicine formula in type 2 diabetic rats.
Insulin Resistance
Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus.
Insulin Resistance
Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Insulin Resistance
Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats.
Insulin Resistance
Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes.
Insulin Resistance
Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals.
Insulin Resistance
Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle.
Insulin Resistance
At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Insulin Resistance
BAG6 contributes to glucose uptake by supporting the cell surface translocation of the glucose transporter GLUT4.
Insulin Resistance
Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats.
Insulin Resistance
Beneficial effects of Aronia melanocarpa berry extract on hepatic insulin resistance in type 2 diabetes mellitus rats.
Insulin Resistance
Biologic activities of naturally occurring human insulin receptor mutations. Evidence that metabolic effects of insulin can be mediated by a kinase-deficient insulin receptor mutant.
Insulin Resistance
Birthweight and fetal glycosylated hemoglobin at birth in newborns carrying the GLUT1 XbaI gene polymorphism.
Insulin Resistance
Bisphenol A and octylphenol exacerbate type 1 diabetes mellitus by disrupting calcium homeostasis in mouse pancreas.
Insulin Resistance
Bisphenol A disrupts glucose transport and neurophysiological role of IR/IRS/AKT/GSK3? axis in the brain of male mice.
Insulin Resistance
Carbenoxolone enhances peripheral insulin sensitivity and GLUT4 expression in skeletal muscle of obese rats: Potential participation of UBC9 protein.
Insulin Resistance
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Insulin Resistance
Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss.
Insulin Resistance
CELL BIOLOGY SYMPOSIUM: Practical application of the basic aspects of GLUT4 membrane trafficking and insulin signaling on issues related to animal agriculture.
Insulin Resistance
Cellular stress causes accumulation of the glucose transporter at the surface of cells independently of their insulin sensitivity.
Insulin Resistance
Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.
Insulin Resistance
Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence.
Insulin Resistance
Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.
Insulin Resistance
Changes in the gene expression of adiponectin and glucose transporter 12 (GLUT12) in lactating and non-lactating cows
Insulin Resistance
CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.
Insulin Resistance
Chebulagic acid attenuates HFD/Streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR ? and GLUT 4 in type 2 diabetic rats.
Insulin Resistance
Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging.
Insulin Resistance
Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium.
Insulin Resistance
Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle.
Insulin Resistance
Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance.
Insulin Resistance
Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles.
Insulin Resistance
Comparative effects of single-mode vs. duration-matched concurrent exercise training on body composition, low-grade inflammation, and glucose regulation in sedentary, overweight, middle-aged men.
Insulin Resistance
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
Insulin Resistance
Concentration of Catechins and Caffeine in Black Tea Affects Suppression of Fat Accumulation and Hyperglycemia in High-fat Diet-fed Mice
Insulin Resistance
Conjugated linoleic acid supplementation enhances insulin sensitivity and peroxisome proliferator-activated receptor gamma and glucose transporter type 4 protein expression in the skeletal muscles of rats during endurance exercise.
Insulin Resistance
Cooperative effects of galanin and leptin on alleviation of insulin resistance in adipose tissue of diabetic rats.
Insulin Resistance
Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus.
Insulin Resistance
Crosstalk between exercise and galanin system alleviates insulin resistance.
Insulin Resistance
Cysteine string protein 1 (CSP1) modulates insulin sensitivity by attenuating glucose transporter 4 (GLUT4) vesicle docking with the plasma membrane.
Insulin Resistance
Decreased brain and muscle ARNT-like protein 1 expression mediated the contribution of hyperandrogenism to insulin resistance in polycystic ovary syndrome.
Insulin Resistance
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting.
Insulin Resistance
Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
Insulin Resistance
Defective insulin-stimulated GLUT4 translocation in brown adipocytes induces systemic glucose homeostasis dysregulation independent of thermogenesis in female mice.
Insulin Resistance
Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1?-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.
Insulin Resistance
Development of insulin sensitivity in rat skeletal muscle. Studies of glucose transporter and insulin receptor mRNA levels.
Insulin Resistance
Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
Insulin Resistance
Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.
Insulin Resistance
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Insulin Resistance
Dietary Sea Buckthorn Pomace Induces Beige Adipocyte Formation in Inguinal White Adipose Tissue in Lambs.
Insulin Resistance
Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep.
Insulin Resistance
Divergent molecular mechanisms for insulin-resistant glucose transport in muscle and adipose cells in vivo.
Insulin Resistance
Effect of ?-sitosterol on glucose homeostasis by sensitization of insulin resistance via enhanced protein expression of PPR? and glucose transporter 4 in high fat diet and streptozotocin-induced diabetic rats.
Insulin Resistance
Effect of a proanthocyanidin-rich extract from longan flower on markers of metabolic syndrome in fructose-fed rats.
Insulin Resistance
Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats.
Insulin Resistance
Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity.
Insulin Resistance
Effect of Baicalein on GLUT4 Translocation in Adipocytes of Diet-Induced Obese Mice.
Insulin Resistance
Effect of combination of chlorella intake and aerobic exercise training on glycemic control in type 2 diabetic rats.
Insulin Resistance
Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle.
Insulin Resistance
Effect of exercise training on skeletal muscle protein expression in relation to insulin sensitivity: Per-protocol analysis of a randomized controlled trial (GO-ACTIWE).
Insulin Resistance
Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats.
Insulin Resistance
Effects of hyperinsulinemia on glucose and lipid transporter expression in insulin-sensitive horses.
Insulin Resistance
Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Insulin Resistance
Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.
Insulin Resistance
Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
Insulin Resistance
Electroacupuncture combined with acarbose improves insulin sensitivity via peroxisome proliferator-activated receptor ? activation and produces a stronger glucose-lowering effect than acarbose alone in a rat model of steroid-induced insulin resistance.
Insulin Resistance
Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men.
Insulin Resistance
Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Insulin Resistance
Evaluation of in vitro/in vivo anti-diabetic effects and identification of compounds from Physalis alkekengi.
Insulin Resistance
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.
Insulin Resistance
Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
Insulin Resistance
Exercise improved lipid metabolism and insulin sensitivity in rats fed a high-fat diet by regulating glucose transporter 4 (GLUT4) and musclin expression.
Insulin Resistance
Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats.
Insulin Resistance
Exercise training prevents maturation-induced decrease in insulin sensitivity.
Insulin Resistance
Exercise training prevents skeletal muscle plasma membrane cholesterol accumulation, cortical actin filament loss, and insulin resistance in C57BL/6J mice fed a western-style high-fat diet.
Insulin Resistance
Exercise type and muscle fiber specific induction of caveolin-1 expression for insulin sensitivity of skeletal muscle.
Insulin Resistance
Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats.
Insulin Resistance
Exercise-induced increase in IL-6 level enhances GLUT4 expression and insulin sensitivity in mouse skeletal muscle.
Insulin Resistance
Expansion of the homeostasis model assessment of ?-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2.
Insulin Resistance
Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: dexamethasone decreases transporter mRNA in primary cultured adipocytes.
Insulin Resistance
Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors.
Insulin Resistance
Expression of GLUT4 glucose transporter protein in adipose tissue and skeletal muscle from streptozotocin-induced diabetic pregnant rats.
Insulin Resistance
Fibroblast growth factor-1 as a mediator of paracrine effects of canine adipose tissue-derived mesenchymal stem cells on in vitro-induced insulin resistance models.
Insulin Resistance
Four weeks of exercise early in life reprograms adult skeletal muscle insulin resistance caused by a paternal high-fat diet.
Insulin Resistance
From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance.
Insulin Resistance
G-protein coupled receptor 120 is involved in glucose metabolism in fat cells.
Insulin Resistance
Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats.
Insulin Resistance
Galanin participates in the functional regulation of the diabetic heart.
Insulin Resistance
Ganoderma lucidum Extract Reduces Insulin Resistance by Enhancing AMPK Activation in High-Fat Diet-Induced Obese Mice.
Insulin Resistance
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Insulin Resistance
Gestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring.
Insulin Resistance
Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation.
Insulin Resistance
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
Insulin Resistance
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.
Insulin Resistance
Glucose availability regulates nicotinamide N-methyltransferase expression in adipocytes.
Insulin Resistance
Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4.
Insulin Resistance
Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance.
Insulin Resistance
Glucose transporter protein responses to selective hyperglycemia or hyperinsulinemia in fetal sheep.
Insulin Resistance
GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance.
Insulin Resistance
GluT4: A central player in hippocampal memory and brain insulin resistance.
Insulin Resistance
Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
Insulin Resistance
Green and black tea suppress hyperglycemia and insulin resistance by retaining the expression of glucose transporter 4 in muscle of high-fat diet-fed C57BL/6J mice.
Insulin Resistance
Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet.
Insulin Resistance
Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
Insulin Resistance
Heterotypic endosomal fusion as an initial trigger for insulin-induced glucose transporter 4 (GLUT4) translocation in skeletal muscle.
Insulin Resistance
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Insulin Resistance
High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated phosphatidylinositol 3-kinase activity and glucose transport.
Insulin Resistance
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling.
Insulin Resistance
HIV protease inhibitors acutely impair glucose-stimulated insulin release.
Insulin Resistance
Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors.
Insulin Resistance
Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes.
Insulin Resistance
Hyperbaric Oxygen Ameliorates Insulin Sensitivity by Increasing GLUT4 Expression in Skeletal Muscle and Stimulating UCP1 in Brown Adipose Tissue in T2DM Mice.
Insulin Resistance
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Insulin Resistance
Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor.
Insulin Resistance
Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin.
Insulin Resistance
Impact of flaxseed and soy nuts as dietary supplements on lipid profile, insulin sensitivity, and GLUT4 expression in ovariectomized rats.
Insulin Resistance
Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition.
Insulin Resistance
Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats.
Insulin Resistance
Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats.
Insulin Resistance
Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.
Insulin Resistance
Improved insulin sensitivity associated with reduced mitochondrial complex IV assembly and activity.
Insulin Resistance
Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise.
Insulin Resistance
Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-?B and sterol regulatory element-binding protein-1 in adipocytes.
Insulin Resistance
Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose--potential implications for insulin resistance.
Insulin Resistance
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
Insulin Resistance
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Insulin Resistance
Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lamb.
Insulin Resistance
Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats.
Insulin Resistance
Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation.
Insulin Resistance
Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.
Insulin Resistance
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Insulin Resistance
Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.
Insulin Resistance
Insulin resistance in HIV infection: drugs, host responses, or restoration to health?
Insulin Resistance
Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.
Insulin Resistance
Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle.
Insulin Resistance
Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart.
Insulin Resistance
Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4.
Insulin Resistance
Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.
Insulin Resistance
Intact glucose transport in morphologically altered denervated skeletal muscle from quadriplegic patients.
Insulin Resistance
Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
Insulin Resistance
Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ.
Insulin Resistance
Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats.
Insulin Resistance
Lifelong Physical Activity Prevents Aging-Associated Insulin Resistance in Human Skeletal Muscle Myotubes via Increased Glucose Transporter Expression.
Insulin Resistance
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM.
Insulin Resistance
Lipid induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling.
Insulin Resistance
Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.
Insulin Resistance
Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
Insulin Resistance
Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity.
Insulin Resistance
Maternal periodontitis decreases plasma membrane GLUT4 content in skeletal muscle of adult offspring.
Insulin Resistance
Maternal protein restriction in rats leads to reduced PGC-1? expression via altered DNA methylation in skeletal muscle.
Insulin Resistance
Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
Insulin Resistance
Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.
Insulin Resistance
Metabolic syndrome and insulin resistance: perioperative considerations.
Insulin Resistance
Metabolically healthy obese vs. Metabolic syndrome - The crosslink between nutritional exposure to bisphenols and physical exercise.
Insulin Resistance
Metabolism and acetylation contribute to leucine-mediated inhibition of cardiac glucose uptake.
Insulin Resistance
MicroRNA-17 impairs glucose metabolism in insulin-resistant skeletal muscle via repressing glucose transporter 4 expression.
Insulin Resistance
MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Insulin Resistance
Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol.
Insulin Resistance
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Insulin Resistance
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
Insulin Resistance
Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle.
Insulin Resistance
Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats.
Insulin Resistance
Muscle insulin resistance amended with exercise training: role of GLUT4 expression.
Insulin Resistance
Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors.
Insulin Resistance
Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Insulin Resistance
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes.
Insulin Resistance
Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.
Insulin Resistance
Naringenin Promotes Thermogenic Gene Expression in Human White Adipose Tissue.
Insulin Resistance
Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats.
Insulin Resistance
Nutraceutical effects of fucoxanthin for obesity and diabetes therapy: a review.
Insulin Resistance
Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with ?-cell mass.
Insulin Resistance
OS 15-09 DOES ACE2-ANGIOTENSIN-(1-7) AXIS PROTECT FROM AGING-ASSOCIATED LOSS OF SKELETAL MUSCLE FUNCTION?
Insulin Resistance
Overexpression of Insulin Degrading Enzyme could Greatly Contribute to Insulin Down-regulation Induced by Short-Term Swimming Exercise.
Insulin Resistance
Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in post-infarct heart failure.
Insulin Resistance
Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review.
Insulin Resistance
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
Insulin Resistance
Peripheral insulin resistance in ILK-depleted mice by reduction of GLUT4 expression.
Insulin Resistance
PI3K-GLUT4 Signal Pathway Associated with Effects of EX-B3 Electroacupuncture on Hyperglycemia and Insulin Resistance of T2DM Rats.
Insulin Resistance
Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes.
Insulin Resistance
Placental restriction reduces insulin sensitivity and expression of insulin signaling and glucose transporter genes in skeletal muscle, but not liver, in young sheep.
Insulin Resistance
Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus.
Insulin Resistance
Polyphenols activate energy sensing network in insulin resistant models.
Insulin Resistance
Postreceptor defect in insulin action in streptozotocin-induced diabetic rats.
Insulin Resistance
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Insulin Resistance
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
Insulin Resistance
Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.
Insulin Resistance
Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: Involvement of the adaptive antioxidant response.
Insulin Resistance
Protein restriction during gestation alters histone modifications at the glucose transporter 4 (GLUT4) promoter region and induces GLUT4 expression in skeletal muscle of female rat offspring.
Insulin Resistance
Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic ?-cell proliferation in type 2 diabetic mice.
Insulin Resistance
Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.
Insulin Resistance
Randomized clinical trial to compare the effects of preoperative oral carbohydrate versus placebo on insulin resistance after colorectal surgery.
Insulin Resistance
Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis.
Insulin Resistance
Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation-induced MCP1 expression in adipocytes.
Insulin Resistance
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
Insulin Resistance
Reduced Insulin Resistance Contributes to the Beneficial Effect of Protein Tyrosine Phosphatase-1B Deletion in a Mouse Model of Sepsis.
Insulin Resistance
Reduced Slc2a4/GLUT4 expression in subcutaneous adipose tissue of monosodium glutamate obese mice is recovered after atorvastatin treatment.
Insulin Resistance
Repeated prolonged whole-body low-intensity exercise: effects on insulin sensitivity and limb muscle adaptations.
Insulin Resistance
Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle.
Insulin Resistance
Resistance training is medicine: effects of strength training on health.
Insulin Resistance
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Insulin Resistance
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Insulin Resistance
Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone.
Insulin Resistance
Role of retinol-binding protein 4 in the pathogenesis of Type 2 diabetes.
Insulin Resistance
Rosiglitazone balances insulin-induced exo- and endocytosis in single 3T3-L1 adipocytes.
Insulin Resistance
Route of nutrient delivery affects insulin sensitivity and liver glucose transporter expression in rat.
Insulin Resistance
Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.
Insulin Resistance
Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes.
Insulin Resistance
Sexually Dimorphic Diet-Induced Insulin Resistance in Obese Tissue Inhibitor of Metalloproteinase-2 (TIMP-2)-Deficient Mice.
Insulin Resistance
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
Insulin Resistance
SPARC is over-expressed in adipose tissues of diet-induced obese rats and causes insulin resistance in 3T3-L1 adipocytes.
Insulin Resistance
Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.
Insulin Resistance
Subcellular distribution and phosphorylation state of insulin receptors from insulin- and isoproterenol-treated rat adipose cells.
Insulin Resistance
Supplementation of pyruvate prevents palmitate-induced impairment of glucose uptake in C2 myotubes.
Insulin Resistance
Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Insulin Resistance
Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects.
Insulin Resistance
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
Insulin Resistance
The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells.
Insulin Resistance
The anti-diabetic effect of anthocyanins in streptozotocin-induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosis.
Insulin Resistance
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
Insulin Resistance
The effect of BPA exposure on insulin resistance and type 2 diabetes - The impact of muscle contraction.
Insulin Resistance
The effect of electric field, magnetic field, and infrared ray combination to reduce HOMA-IR index and GLUT 4 in diabetic model of Mus musculus.
Insulin Resistance
The effect of exercise on epigenetic modifications of PGC1: The impact on type 2 diabetes.
Insulin Resistance
The effect of exercise on skeletal muscle glucose uptake in type 2 diabetes: An epigenetic perspective.
Insulin Resistance
THE EFFECT OF SALBUTAMOL ON PGC-1 ? AND GLUT4 mRNA EXPRESSION IN THE LIVER AND MUSCLE OF ELDERLY DIABETIC MICE.
Insulin Resistance
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.
Insulin Resistance
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Insulin Resistance
The Interacting Domains of PREP1 and p160 are Endowed with a Remarkable Structural Stability.
Insulin Resistance
The neuropeptide galanin benefits insulin sensitivity in subjects with type 2 diabetes.
Insulin Resistance
The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue.
Insulin Resistance
Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes.
Insulin Resistance
TNF-? promotes insulin resistance in obstructive sleep apnea-hypopnea syndrome.
Insulin Resistance
Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.
Insulin Resistance
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell.
Insulin Resistance
Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes.
Insulin Resistance
Usefulness of combining intermittent hypoxia and physical exercise in the treatment of obesity.
Insulin Resistance
[Influence of modified qianjin huanglian pill on pancreas of mice with insulin resistance]
Insulin Resistance
[Overview on hypoglycemic active constituents of traditional Chinese medicine based on insulin receptor signaling pathway].
Insulin Resistance
[Progress in the role of oxidative stress in the pathogenesis of type 2 diabetes].
Insulin Resistance
[Resistive training reduces inflammation in skeletal muscle and improves the peripheral insulin sensitivity in obese rats induced by hyperlipidic diet].
Insulin Resistance
[Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)]
Insulinoma
Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells.
Insulinoma
Effects of sodium butyrate on glucose transporter and glucose-phosphorylating enzyme gene expression in RINm5F insulinoma cells.
Insulinoma
Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.
Insulinoma
GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin A.
Insulinoma
Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA.
Insulinoma
Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic ?-cells.
Intellectual Disability
Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
Intellectual Disability
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Intellectual Disability
Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
Intellectual Disability
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
Intellectual Disability
Symptomatic West Syndrome Secondary to Glucose Transporter-1(GLUT1) Deficiency with Complete Response to 4:1 Ketogenic Diet.
Intracranial Aneurysm
Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation.
Ischemic Stroke
2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-?-D-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3.
Ischemic Stroke
Cerebral glucose transporter: The possible therapeutic target for ischemic stroke.
Ischemic Stroke
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke.
Keratosis
Fluorodeoxyglucose uptake positive-seborrheic keratosis on positron emission tomography may result from high expression of glucose transporter.
Ketosis
Sodium glucose transporter 2 inhibition, euglycemic ketosis and bone mineral loss: Refining clinical practices.
Kidney Neoplasms
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer.
Kidney Neoplasms
[Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]
Lafora Disease
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Lesch-Nyhan Syndrome
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Leukemia
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Leukemia
Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
Leukemia
GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
Leukemia
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Leukemia
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Leukemia
Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.
Leukemia, Myeloid, Acute
Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
Leukemia, T-Cell
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1.
Leukemia, T-Cell
Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Leukemia, T-Cell
Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
Leukemia, T-Cell
GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
Leukemia, T-Cell
Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1.
Leukemia, T-Cell
Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
Leukemia, T-Cell
The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Leukocytosis
Physiological leukocytosis during pregnancy is associated with changes in glucose transporter expression of maternal peripheral blood granulocytes and monocytes.
Leukoencephalopathies
Leukoencephalopathy in infancy with glucose transporter type 1 deficiency syndrome.
Lichen Planus, Oral
Hypoxia-inducible factor-1? and glucose transporter 1 in the malignant transformation of oral lichen planus.
Lipoma
Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue.
Liver Diseases
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.
Liver Diseases, Alcoholic
Alterations in glucose transporter proteins in alcoholic liver disease in the rat.
Liver Failure, Acute
Selectively increased expression of the astrocytic/endothelial glucose transporter protein GLUT1 in acute liver failure.
Liver Neoplasms
In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter.
Lung Neoplasms
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Lung Neoplasms
Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression.
Lung Neoplasms
Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.
Lung Neoplasms
Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Lung Neoplasms
Deficient glucose uptake is linked to impaired Glut1 expression upon CD3/CD28 stimulation in memory T cells from pleural effusions secondary to lung cancer.
Lung Neoplasms
Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
Lung Neoplasms
Differentiation of histological subtypes in lung cancer with 18F-FDG-PET 3-point imaging and kinetic analysis.
Lung Neoplasms
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Lung Neoplasms
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Lung Neoplasms
Expression and clinical significance of glucose transporter 1 mRNA in bronchial brushing liquid-based cytology specimens from patients with and without lung cancer.
Lung Neoplasms
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Lung Neoplasms
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Lung Neoplasms
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Lung Neoplasms
Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Lung Neoplasms
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Lung Neoplasms
Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Lung Neoplasms
Glucose transporter expression in developing fetal lungs and lung neoplasms.
Lung Neoplasms
Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.
Lung Neoplasms
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.
Lung Neoplasms
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-d-glucose uptake.
Lung Neoplasms
Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Lung Neoplasms
IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
Lung Neoplasms
Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
Lung Neoplasms
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.
Lung Neoplasms
Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk.
Lung Neoplasms
Lung squamous cell carcinoma exhibits a targetable glucose dependency unique among non-small cell lung cancers.
Lung Neoplasms
MUC1 Expression in Pulmonary Metastatic Tumors: A Comparison of Primary Lung Cancer.
Lung Neoplasms
Nonimmobilized Biomaterial Capillary Electrophoresis for Screening Drugs Targeting Human Glucose Transporter 1.
Lung Neoplasms
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
Lung Neoplasms
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Lung Neoplasms
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Lung Neoplasms
Prognostic significance of genetic variants in GLUT1 in stage III non-small cell lung cancer treated with radiotherapy.
Lung Neoplasms
Protein kinase C-iota-mediated glycolysis promotes non-small-cell lung cancer progression.
Lung Neoplasms
Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Lung Neoplasms
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
Lung Neoplasms
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.
Lung Neoplasms
Sodium/iodide symporter expression in primary lung cancer and comparison with glucose transporter 1 expression.
Lung Neoplasms
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Lung Neoplasms
Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells.
Lung Neoplasms
Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer.
Lung Neoplasms
[Expression of GLUT1 protein and its relationship with uptake of FDG in non-small cell lung cancer tissues.]
Lymphatic Metastasis
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
Lymphatic Metastasis
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Lymphatic Metastasis
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Lymphatic Metastasis
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Lymphatic Metastasis
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Lymphoma
18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
Lymphoma
Correlation between positron emission tomography findings and glucose transporter 1, 3 and L-type amino acid transporter 1 mRNA expression in primary central nervous system lymphomas.
Lymphoma
Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma.
Lymphoma
Effect of Letrozole, a selective aromatase inhibitor, on testicular activities in adult mice: Both in vivo and in vitro study.
Lymphoma
Expression of hypoxia-inducible factor 1?, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
Lymphoma
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Lymphoma
Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
Lymphoma
LncRNA GASL1 inhibits growth and promotes expression of apoptosis-associated proteins in prostate carcinoma cells through GLUT-1.
Lymphoma
Lysophosphatidic acid promotes survival of T lymphoma cells by altering apoptosis and glucose metabolism.
Lymphoma, B-Cell
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Lymphoma, B-Cell
Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways.
Lymphoma, B-Cell
Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone.
Lymphoma, B-Cell
Diagnostic Roles of Immunohistochemistry in Thymic Tumors: Differentiation between Thymic Carcinoma and Thymoma.
Lymphoma, B-Cell
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Lymphoma, B-Cell
LncRNA GASL1 inhibits growth and promotes expression of apoptosis-associated proteins in prostate carcinoma cells through GLUT-1.
Lymphoma, Large B-Cell, Diffuse
Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Lysosomal Storage Diseases
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Lysosomal Storage Diseases
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Malabsorption Syndromes
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.
Malabsorption Syndromes
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.
Malaria
A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Malaria
Insight Into the Pathogenesis of Fetal Growth Restriction in Placental Malaria: Decreased Placental Glucose Transporter Isoform 1 Expression.
Malaria
Microarray analysis of PBMC after Plasmodium falciparum infection: Molecular insights into disease pathogenesis.
Malaria
Reduction of Mosquito Survival in Mice Vaccinated with Anopheles stephensi Glucose Transporter.
Malnutrition
Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice.
Malnutrition
Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep.
Malnutrition
Effects of chronic undernutrition on glucose uptake and glucose transporter proteins in rat heart.
Malnutrition
Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition.
Malnutrition
Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels.
Malnutrition
Pre- and early-postnatal nutrition modify gene and protein expressions of muscle energy metabolism markers and phospholipid Fatty Acid composition in a muscle type specific manner in sheep.
Malnutrition
Up-regulation of phosphatidylinositol 3-kinase and glucose transporter 4 in muscle of rats subjected to maternal undernutrition.
Melanoma
4'-Bromo-resveratrol, a dual Sirtuin-1 and Sirtuin-3 inhibitor, inhibits melanoma cell growth through mitochondrial metabolic reprogramming.
Melanoma
Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Melanoma
Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.
Melanoma
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Melanoma
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
Melanoma
Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells.
Melanoma
LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling.
Melanoma
Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
MELAS Syndrome
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
Meningioma
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.
Meningioma
Expression of GLUT3 and HIF-1? in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.
Meningioma
Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
Meningioma
Immunohistochemical Detection of CD34, E-cadherin, Claudin-1, Glucose Transporter 1, Laminin, and Protein Gene Product 9.5 in 28 Canine and 8 Feline Meningiomas.
Meningitis
Escherichia coli K1 Modulates Peroxisome Proliferator-Activated Receptor ? and Glucose Transporter 1 at the Blood-Brain Barrier in Neonatal Meningitis.
Meningomyelocele
Association of facilitated glucose transporter 2 gene variants with the myelomeningocele phenotype.
Menkes Kinky Hair Syndrome
A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport.
Menkes Kinky Hair Syndrome
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Mesothelioma
Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease.
Mesothelioma
Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Mesothelioma, Malignant
Diagnostic value of GLUT-1 in distinguishing malignant mesothelioma from reactive mesothelial cells: a meta-analysis.
Mesothelioma, Malignant
Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Mesothelioma, Malignant
Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.
Mesothelioma, Malignant
Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
Mesothelioma, Malignant
[Expression of glucose transporter protein 1 and desmin in reactive mesothelial hyperplasia and epithelioid malignant mesothelioma].
Metabolic Diseases
MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue.
Metabolic Syndrome
Aerobic exercise training induces metabolic benefits in rats with metabolic syndrome independent of dietary changes.
Metabolic Syndrome
CASE FINDING FOR HYPOTHYROIDISM SHOULD INCLUDE TYPE 2 DIABETES AND METABOLIC SYNDROME PATIENTS: A LATIN AMERICAN THYROID SOCIETY (LATS) POSITION STATEMENT.
Metabolic Syndrome
Decreased glucose transporter protein (GLUT4) in skeletal muscle of hypertriglyceridaemic insulin-resistant rat.
Metabolic Syndrome
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
Metabolic Syndrome
Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
Metabolic Syndrome
Insulin resistance and muscle insulin receptor substrate-1 serine hyperphosphorylation.
Metabolic Syndrome
Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
Metabolic Syndrome
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Metabolic Syndrome
Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver.
Metabolism, Inborn Errors
Fanconi-Bickel syndrome--a congenital defect of the liver-type facilitative glucose transporter. SSIEM Award. Society for the Study of Inborn Errors of Metabolism.
Metabolism, Inborn Errors
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Metabolism, Inborn Errors
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
methylenetetrahydrofolate dehydrogenase (nad+) deficiency
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Microcephaly
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Microcephaly
Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.
Microcephaly
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Microcephaly
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Microcephaly
Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.
Microcephaly
Glucose Transporter Type 1 Deficiency Syndrome: Developmental Delay and Early-Onset Ataxia in a Novel Mutation of the SLC2A1 Gene.
Microcephaly
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
Microcephaly
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
Microcephaly
Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome.
Microcephaly
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
Microcephaly
[Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome]
Migraine Disorders
Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature.
Mitochondrial Diseases
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Mitochondrial Diseases
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Motor Neuron Disease
Evaluation of glucose tolerance and intestinal luminal membrane glucose transporter function in horses with equine motor neuron disease.
Mouth Neoplasms
Elevated Sad1 and UNC84 Domain Containing 2 (SUN2) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA).
Mouth Neoplasms
Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.
Movement Disorders
Allelic variations of glut-1 deficiency syndrome: the chinese experience.
Movement Disorders
Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.
Movement Disorders
Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
Movement Disorders
Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy.
Movement Disorders
Glucose transporter type 1 deficiency due to SLC2A1 gene mutations--a rare but treatable cause of metabolic epilepsy and extrapyramidal movement disorder; own experience and literature review.
Movement Disorders
NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.
Movement Disorders
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
Movement Disorders
Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
Movement Disorders
[Glucose transporter 1 deficiency syndrome: features of movement disorders, diagnosis and treatment].
Multiple Myeloma
Inhibition of glucose transporter 1 induces apoptosis and sensitizes multiple myeloma cells to conventional chemotherapeutic agents.
Multiple Sclerosis
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Myocardial Infarction
Aerobic training prior to myocardial infarction increases cardiac GLUT4 and partially preserves heart function in spontaneously hypertensive rats.
Myocardial Ischemia
Increased sarcolemmal glucose transporter abundance in myocardial ischemia.
Myocardial Ischemia
Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions.
Myocardial Ischemia
Post-ischemic stimulation of 2-deoxyglucose uptake in rat myocardium: role of translocation of Glut-4.
Myocardial Ischemia
Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.
Myocardial Ischemia
sDR5-Fc inhibits macrophage M1 polarization by blocking the glycolysis.
Myocardial Stunning
Enhancement of glucose uptake in stunned myocardium: role of glucose transporter.
Myoclonic Epilepsies, Progressive
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Myoclonus
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Nasopharyngeal Carcinoma
Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-?B Signaling Pathways.
Necrobiosis Lipoidica
Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica.
Neoplasm Metastasis
18F-fluoromisonidazole positron emission tomography may be applicable in the evaluation of colorectal cancer liver metastasis.
Neoplasm Metastasis
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
Neoplasm Metastasis
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Neoplasm Metastasis
Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.
Neoplasm Metastasis
Characterization of glycolysis-related gene expression in malignant melanoma.
Neoplasm Metastasis
Collapsing the Metabolic PON2zi Scheme in Pancreatic Ductal Adenocarcinoma.
Neoplasm Metastasis
Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Neoplasm Metastasis
Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer.
Neoplasm Metastasis
Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.
Neoplasm Metastasis
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Neoplasm Metastasis
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Neoplasm Metastasis
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Neoplasm Metastasis
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Neoplasm Metastasis
GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation.
Neoplasm Metastasis
Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue.
Neoplasm Metastasis
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
Neoplasm Metastasis
HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Neoplasm Metastasis
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Neoplasm Metastasis
Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Neoplasm Metastasis
Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis.
Neoplasm Metastasis
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Neoplasm Metastasis
Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Neoplasm Metastasis
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Neoplasm Metastasis
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Neoplasm Metastasis
Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Neoplasm Metastasis
Quantitative protein expression of blood-brain barrier transporters in the vasculature of brain metastases of patients with lung and breast cancer.
Neoplasm Metastasis
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Neoplasm Metastasis
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Neoplasm Metastasis
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Neoplasm Metastasis
Tris-base buffer: a promising new inhibitor for cancer progression and metastasis.
Neoplasm Metastasis
Vascular expression of glucose transporter in and around hematogenous metastases of the human brain. Immunohistochemical observations.
Neoplasms
(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
Neoplasms
(18)F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: A clinicopathological study.
Neoplasms
(18)FDG PET for grading malignancy in thymic epithelial tumors: Significant differences in (18)FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study.
Neoplasms
18-Carbon polyunsaturated fatty acids ameliorate palmitate-induced inflammation and insulin resistance in mouse C2C12 myotubes.
Neoplasms
18F-FDG uptake in well-differentiated neuroendocrine tumors correlates with both Ki-67 and VHL pathway inactivation.
Neoplasms
18F-FDG uptake on PET could be a?predictive marker of Excision Repair Cross-Complementation Group 1 (ERCC1) expression in patients with thoracic neoplasms?
Neoplasms
18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Neoplasms
18F-FES and 18F-FDG PET for Differential Diagnosis and Quantitative Evaluation of Mesenchymal Uterine Tumors: Correlation with Immunohistochemical Analysis.
Neoplasms
18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice.
Neoplasms
2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
Neoplasms
4-Hydroxyisoleucine improves insulin resistance in HepG2 cells by decreasing TNF-? and regulating the expression of insulin signal transduction proteins.
Neoplasms
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Neoplasms
A Nonsense Mitochondrial DNA Mutation Associates with Dysfunction of HIF1? in a Von Hippel-Lindau Renal Oncocytoma.
Neoplasms
A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.
Neoplasms
A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
Neoplasms
A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.
Neoplasms
A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
Neoplasms
A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
Neoplasms
A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
Neoplasms
A tumor-associated glycosylation change in the glucose transporter GLUT1 controlled by tumor suppressor function in human cell hybrids.
Neoplasms
Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1?, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Neoplasms
Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.
Neoplasms
Abnormal facilitative glucose transporter gene expression in human islet cell tumors.
Neoplasms
ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with 18F-FDG PET and Correlation with Genotype and GLUT4 Expression.
Neoplasms
Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Neoplasms
Adaptation to HIF1? Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.
Neoplasms
Adenine Nucleotide Translocase 2 as an Enzyme Related to [18F] FDG Accumulation in Various Cancers.
Neoplasms
Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
Neoplasms
Ameliorative effect of fermentable fibres on adiposity and insulin resistance in C57BL/6 mice fed a high-fat and sucrose diet.
Neoplasms
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.
Neoplasms
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma.
Neoplasms
Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Neoplasms
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Neoplasms
Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping.
Neoplasms
Anti-Hyperglycemic Effect of Fermented Ginseng in Type 2 Diabetes Mellitus Mouse Model.
Neoplasms
Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.
Neoplasms
Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice.
Neoplasms
Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism.
Neoplasms
Antitumor effects of WNT2B silencing in GLUT1 overexpressing cisplatin resistant head and neck squamous cell carcinoma.
Neoplasms
Anti PD-1 treatment increases [18F]FDG uptake by cancer cells in a mouse B16F10 melanoma model.
Neoplasms
Applicability of 99mTc-HL91, a putative hypoxic tracer, to detection of tumor hypoxia.
Neoplasms
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Neoplasms
Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1? and glucose transporter 1 in non-small cell lung cancer.
Neoplasms
Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration.
Neoplasms
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
Neoplasms
Bioactive compounds in plant materials for the prevention of diabetesand obesity.
Neoplasms
Biologic correlates of (18)F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Neoplasms
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Neoplasms
Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.
Neoplasms
Breast cancer proteomics reveals correlation between Estrogen Receptor status and differential phosphorylation of PGRMC1.
Neoplasms
Cancer cell spheroids are a better screen for the photodynamic efficiency of glycosylated photosensitizers.
Neoplasms
Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186.
Neoplasms
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
Neoplasms
Carpesium abrotanoides (L.) Root as a Potential Source of Natural Anticancer Compounds: Targeting Glucose Metabolism and PKM2/HIF-1? Axis of Breast Cancer Cells.
Neoplasms
CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma.
Neoplasms
Cell Microenvironment-Controlled Antitumor Drug Releasing-Nanomicelles for GLUT1-Targeting Hepatocellular Carcinoma Therapy.
Neoplasms
Cellular and molecular features of lipoma tissue: comparison with normal adipose tissue.
Neoplasms
Characterization of a near-infrared fluorescent DCPO-tagged glucose analogue for cancer cell imaging.
Neoplasms
Chromosomal assignment of seven genes on canine chromosomes by fluorescence in situ hybridization.
Neoplasms
Clinical Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography in Superficial Esophageal Squamous Cell Carcinoma.
Neoplasms
Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹?F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Neoplasms
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Neoplasms
Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Neoplasms
Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.
Neoplasms
Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers.
Neoplasms
Combination of Palmitic Acid and Methylseleninic Acid Induces Mitochondria-Dependent Apoptosis via Attenuation of the IRE1? Arm and Enhancement of CHOP in Hepatoma.
Neoplasms
Comparative effects of single-mode vs. duration-matched concurrent exercise training on body composition, low-grade inflammation, and glucose regulation in sedentary, overweight, middle-aged men.
Neoplasms
Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
Neoplasms
Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer.
Neoplasms
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
Neoplasms
Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo.
Neoplasms
Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target.
Neoplasms
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Neoplasms
Construction of a GLUT-1 and HIF-1? gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.
Neoplasms
Correlation and expression analysis of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.
Neoplasms
Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography.
Neoplasms
Correlation between biological marker expression and fluorine-18 fluorodeoxyglucose uptake in hepatocellular carcinoma.
Neoplasms
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Neoplasms
Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas.
Neoplasms
Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.
Neoplasms
Correlation Between von Hippel-Lindau Gene Expression and Tumor SUVmax and Survival Prognosis in Hepatocellular Carcinoma.
Neoplasms
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
Neoplasms
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Neoplasms
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
Neoplasms
Correspondence re: Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H: Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998; 11:437-443.
Neoplasms
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report.
Neoplasms
Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway.
Neoplasms
Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice.
Neoplasms
Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.
Neoplasms
Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer.
Neoplasms
Design of antitumor agents containing carbohydrate based on GLUT1, and evaluation of antiproliferative activity.
Neoplasms
Determining the immunohistochemical expression of GLUT1 in renal cell carcinoma using the HSCORE method.
Neoplasms
Diacylglycerol kinase ? predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.
Neoplasms
Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients.
Neoplasms
Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Neoplasms
Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
Neoplasms
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Neoplasms
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Neoplasms
Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.
Neoplasms
Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.
Neoplasms
Distinct glycolytic pathway regulation in liver, tumour and skeletal muscle of mice with cancer cachexia.
Neoplasms
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer.
Neoplasms
Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Neoplasms
Down-Regulation of Hypoxia-Inducible Factor-1? and Downstream Glucose Transporter Protein-1 Gene by ?-elemene Enhancing the Radiosensitivity of Lung Adenocarcinoma Transplanted Tumor.
Neoplasms
Downregulating hypoxia-inducible factor 1 alpha augments transcatheter arterial embolization to treat hepatocellular carcinomas in rats.
Neoplasms
Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
Neoplasms
Effect of gemcitabine on the uptake of (18)F-fluorodeoxyglucose and (18)F-fluorothymidine in lung adenocarcinoma A549 cells and the animal tumor model.
Neoplasms
Effect of Glucose on GLUT1-Dependent Intracellular Ascorbate Accumulation and Viability of Thyroid Cancer Cells.
Neoplasms
Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats.
Neoplasms
Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell Line by Antisense Glucose Transporter-1.
Neoplasms
Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.
Neoplasms
Effects of Nigella sativa seed polysaccharides on type 2 diabetic mice and gut microbiota.
Neoplasms
Effects of unilateral nasal obstruction on the characteristics of jaw-closing muscles in growing rats.
Neoplasms
Efficacy of Positron Emission Tomography in distinguishing brain tumours from inflammation.
Neoplasms
EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
Neoplasms
Energy metabolism in glioblastoma stem cells: PPAR? a metabolic adaptor to intratumoral microenvironment.
Neoplasms
Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Neoplasms
Enhanced Antitumor Efficacy by d-Glucosamine-Functionalized and Paclitaxel-Loaded Poly(Ethylene Glycol)-Co-Poly(Trimethylene Carbonate) Polymer Nanoparticles.
Neoplasms
Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction.
Neoplasms
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming.
Neoplasms
Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool.
Neoplasms
Eugenol attenuates inflammatory response and enhances barrier function during lipopolysaccharide-induced inflammation in the porcine intestinal epithelial cells.
Neoplasms
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.
Neoplasms
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Neoplasms
Evaluation of type 2 diabetic mellitus animal models via interactions between insulin and mitogen?activated protein kinase signaling pathways induced by a high fat and sugar diet and streptozotocin.
Neoplasms
Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans.
Neoplasms
Ex vivo responsiveness of head and neck squamous cell carcinoma to glufosfamide, a novel alkylating agent.
Neoplasms
Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Neoplasms
Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.
Neoplasms
Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Neoplasms
Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
Neoplasms
Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.
Neoplasms
Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions.
Neoplasms
Expression of glucose transporter protein-1 (Glut-1) in ocular surface squamous neoplasia.
Neoplasms
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Neoplasms
Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Neoplasms
Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Neoplasms
Expression of Monocarboxylate Transporter 1 Is Associated With Better Prognosis and Reduced Nodal Metastasis in Pancreatic Ductal Adenocarcinoma.
Neoplasms
Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia.
Neoplasms
Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Neoplasms
Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Neoplasms
Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Neoplasms
Expression of the plasma membrane markers aquaporin 1 (AQP1), glucose transporter 1 (GLUT1) and Na, K-ATPase in canine mammary glands and mammary tumours.
Neoplasms
Extranodal Nasal NK/T-Cell Lymphoma: A Rare Oral Presentation and FASN, CD44 and GLUT-1 Expression.
Neoplasms
FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours.
Neoplasms
FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
Neoplasms
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Neoplasms
FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Neoplasms
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Neoplasms
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Neoplasms
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.
Neoplasms
Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.
Neoplasms
Fructose 1,6-Bisphosphatase 1 Expression Reduces 18F-FDG Uptake in Clear Cell Renal Cell Carcinoma.
Neoplasms
Gastric Schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: Report of two cases.
Neoplasms
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1? expression, tumor invasiveness, and patient prognosis.
Neoplasms
Gene expression of tumour necrosis factor and insulin signalling-related factors in subcutaneous adipose tissue during the dry period and in early lactation in dairy cows.
Neoplasms
Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.
Neoplasms
Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet.
Neoplasms
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Neoplasms
Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells.
Neoplasms
Glucose Metabolism Measured by [F]Fluorodeoxyglucose Positron Emission Tomography Is Independent of PTEN/AKT Status in Human Colon Carcinoma Cells.
Neoplasms
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
Neoplasms
Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies.
Neoplasms
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Neoplasms
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Neoplasms
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin ?1/Src/FAK Signaling.
Neoplasms
Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: A useful diagnostic tool for malignant pleural effusions.
Neoplasms
Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.
Neoplasms
Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.
Neoplasms
Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating.
Neoplasms
Glucose transporter expression of an esophageal gastrointestinal tumor detected by F-18 FDG PET/CT.
Neoplasms
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Neoplasms
Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.
Neoplasms
Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Neoplasms
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
Neoplasms
Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
Neoplasms
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Neoplasms
Glucose transporter isotypes switch in T-antigen-transformed pancreatic beta cells growing in culture and in mice.
Neoplasms
Glucose transporter protein 1 expression in mucoepidermoid carcinoma of salivary gland: correlation with grade of malignancy.
Neoplasms
Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro.
Neoplasms
Glucose transporter protein-independent tumor cell accumulation of fluorine-18-AFDG, a lipophilic fluorine-18-FDG analog.
Neoplasms
Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Neoplasms
Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis.
Neoplasms
Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity.
Neoplasms
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Neoplasms
Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells.
Neoplasms
Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation.
Neoplasms
Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.
Neoplasms
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
Neoplasms
Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Neoplasms
Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
Neoplasms
GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Neoplasms
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Neoplasms
GLUT-1 staining of squamous cell carcinomas of the uterine cervix identifies a novel element of invasion.
Neoplasms
GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Neoplasms
Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
Neoplasms
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy.
Neoplasms
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
Neoplasms
GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
Neoplasms
GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
Neoplasms
Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells.
Neoplasms
GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates.
Neoplasms
GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer.
Neoplasms
Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer.
Neoplasms
Growth condition-dependent synchronized changes in transcript levels of type II hexokinase and type 1 glucose transporter in tumor cells.
Neoplasms
H2A Monoubiquitination Links Glucose Availability to Epigenetic Regulation of the Endoplasmic Reticulum Stress Response and Cancer Cell Death.
Neoplasms
Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers.
Neoplasms
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria.
Neoplasms
HIF-1alpha Modulates Energy Metabolism in Cancer Cells by Inducing Over-expression of Specific Glycolytic Isoforms.
Neoplasms
HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Neoplasms
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-d-glucose uptake.
Neoplasms
High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence.
Neoplasms
High Expression of Solute Carrier Family 2 Member 1 (SLC2A1) in Cancer Cells Is an Independent Unfavorable Prognostic Factor in Pediatric Malignant Peripheral Nerve Sheath Tumor.
Neoplasms
High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium.
Neoplasms
High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer.
Neoplasms
Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype.
Neoplasms
Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.
Neoplasms
Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Neoplasms
Hypoxia Imaging and Biological Evaluation of the Radiosensitizing Effect of Oleanolic Acid.
Neoplasms
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Neoplasms
Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.
Neoplasms
Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts.
Neoplasms
Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.
Neoplasms
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.
Neoplasms
Identification of a novel proliferation-dependent C-rich element that mediates inhibition of the rat GLUT1 promoter.
Neoplasms
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
Neoplasms
Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors.
Neoplasms
IL4 receptor ? mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Neoplasms
Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer.
Neoplasms
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neoplasms
Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Neoplasms
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Neoplasms
Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
Neoplasms
Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes.
Neoplasms
Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors.
Neoplasms
Immunohistochemical investigation of metabolic markers fatty acid synthase (FASN) and glucose transporter 1 (GLUT1) in normal endometrium, endometrial hyperplasia, and endometrial malignancy.
Neoplasms
Immunohistochemical localization of glucose transporter 1 and 3 in the scrotal and abdominal testes of a dog.
Neoplasms
Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Neoplasms
Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Neoplasms
Impact of GLUT1 and Ki-67 expression on early?stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
Neoplasms
In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.
Neoplasms
In vivo imaging of hypoxia-inducible factor regulation in a subcutaneous and orthotopic GL261 glioma tumor model using a reporter gene assay.
Neoplasms
In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay.
Neoplasms
Inactivation of O(6)-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors.
Neoplasms
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma.
Neoplasms
Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development.
Neoplasms
Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
Neoplasms
Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma.
Neoplasms
Inhibiting cancer metabolism by aromatic carbohydrate amphiphiles that act as antagonists of the glucose transporter GLUT1.
Neoplasms
Inhibition of Glucose Transporter 1 (GLUT1) Chemosensitized Head and Neck Cancer Cells to Cisplatin.
Neoplasms
Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells.
Neoplasms
Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumour necrosis factor-alpha.
Neoplasms
Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
Neoplasms
Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
Neoplasms
Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
Neoplasms
INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Neoplasms
Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.
Neoplasms
Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle.
Neoplasms
Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.
Neoplasms
Interactions of a Water-Soluble Glycofullerene with Glucose Transporter 1. Analysis of the Cellular Effects on a Pancreatic Tumor Model.
Neoplasms
Interleukin-17A Differentially Induces Inflammatory and Metabolic Gene Expression in the Adipose Tissues of Lean and Obese Mice.
Neoplasms
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Neoplasms
Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms.
Neoplasms
Iodine-125 interstitial brachytherapy reduces tumor growth via Warburg effect inhibition in non-small cell lung cancer A549 ×enografts.
Neoplasms
Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1? signaling pathway.
Neoplasms
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.
Neoplasms
Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.
Neoplasms
L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.
Neoplasms
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction.
Neoplasms
LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors.
Neoplasms
Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Neoplasms
LINC01638 lncRNA promotes cancer cell proliferation in hepatocellular carcinoma by increasing cancer cell glucose uptake.
Neoplasms
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Neoplasms
Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma.
Neoplasms
Long non-coding RNA-NEF targets glucose transportation to inhibit the proliferation of non-small-cell lung cancer cells.
Neoplasms
Low-dose testosterone alleviates vascular damage caused by castration in male rats in puberty via modulation of the PI3K/AKT signaling pathway.
Neoplasms
Low-grade malignant soft-tissue perineurioma: interphase fluorescence in situ hybridization.
Neoplasms
Lung Cancer: A Comparative Study of Metabolism Related Protein Expression in Cancer Cells and Tumor Associated Stroma.
Neoplasms
Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1.
Neoplasms
Maternal periodontitis decreases plasma membrane GLUT4 content in skeletal muscle of adult offspring.
Neoplasms
Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Neoplasms
Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer.
Neoplasms
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Neoplasms
Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.
Neoplasms
Metabolic control analysis indicates a change of strategy in the treatment of cancer.
Neoplasms
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Neoplasms
Metabolome of Pancreatic Juice Delineates Distinct Clinical Profiles of Pancreatic Cancer and Reveals a Link between Glucose Metabolism and PD-1+ Cells.
Neoplasms
Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
Neoplasms
MicroRNA Expression Profile Reveals miR-17-92 and miR-143-145 Cluster in Synchronous Colorectal Cancer.
Neoplasms
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Neoplasms
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo.
Neoplasms
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Neoplasms
Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy.
Neoplasms
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Neoplasms
Monitoring the mechanism of anti-cancer agents to inhibit colorectal cancer cell proliferation: Enzymatic biosensing of glucose combined with molecular docking.
Neoplasms
Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: Role of Monosaccharide Conjugation in Complexation and the Potential of Lung Cancer Targeting and Therapy.
Neoplasms
MUC1 Expression in Pulmonary Metastatic Tumors: A Comparison of Primary Lung Cancer.
Neoplasms
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033.
Neoplasms
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.
Neoplasms
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Neoplasms
Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.
Neoplasms
Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Neoplasms
NF?B up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
Neoplasms
Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site.
Neoplasms
Nonimmobilized Biomaterial Capillary Electrophoresis for Screening Drugs Targeting Human Glucose Transporter 1.
Neoplasms
Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.
Neoplasms
O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms.
Neoplasms
Oncocytic Adrenocortical Carcinoma With Low 18F-FDG Uptake and the Absence of Glucose Transporter 1 Expression.
Neoplasms
One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
Neoplasms
Operable Non-Small Cell Lung Cancer: Correlation of Volumetric Helical Dynamic Contrast-enhanced CT Parameters with Immunohistochemical Markers of Tumor Hypoxia.
Neoplasms
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Neoplasms
Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas.
Neoplasms
Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release.
Neoplasms
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors.
Neoplasms
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Neoplasms
Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Neoplasms
Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Neoplasms
Overexpression of METTL3 associated with the metabolic status on 18F-FDG PET/CT in patients with Esophageal Carcinoma.
Neoplasms
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
Neoplasms
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Neoplasms
PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
Neoplasms
Performance of a 99mTc-labelled 1-thio-beta-D-glucose 2,3,4,6-tetra-acetate analogue in the detection of infections and tumours in mice: a comparison with [18F]FDG.
Neoplasms
Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy.
Neoplasms
Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole.
Neoplasms
Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
Neoplasms
Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.
Neoplasms
Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid.
Neoplasms
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.
Neoplasms
Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer.
Neoplasms
Prediction of Treatment Outcomes in Patients with Chest Wall Sarcoma: Evaluation with PET/CT.
Neoplasms
Predictive factors in radiotherapy for non-small cell lung cancer: present status.
Neoplasms
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Neoplasms
Prevalence of FoxP3(+) Cells in Canine Tumours and Lymph Nodes Correlates Positively with Glucose Transporter 1 Expression.
Neoplasms
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Neoplasms
Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Neoplasms
Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung Adenocarcinoma.
Neoplasms
Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.
Neoplasms
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Neoplasms
Prognostic value of GLUT-1 expression in ovarian surface epithelial tumors: a morphometric study.
Neoplasms
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.
Neoplasms
Protective effect of aqueous seed extract of Vitis Vinifera against oxidative stress, inflammation and apoptosis in the pancreas of adult male rats with diabetes mellitus.
Neoplasms
Protein binding regions of the mRNAs for the 55 kDa tumor necrosis factor receptor and the glucose transporter 1: sequence homology and competition for cellular proteins.
Neoplasms
Proteome analysis of hypoxic glioblastoma cells reveals sequential metabolic adaptation of one-carbon metabolic pathways.
Neoplasms
Putative Mechanisms Responsible for the Antihyperglycemic Action of Lactobacillus paracasei HII01 in Experimental Type 2 Diabetic Rats.
Neoplasms
Quantitative determinations of the steady state transcript levels of hexokinase isozymes and glucose transporter isoforms in normal rat tissues and the malignant tumor cell line AH130.
Neoplasms
Quercetin suppresses insulin receptor signaling through inhibition of the insulin ligand-receptor binding and therefore impairs cancer cell proliferation.
Neoplasms
Reduced tumor vessel density and high expression of glucose transporter 1 suggest tumor hypoxia of squamous cell carcinoma of the esophagus surviving after radiotherapy.
Neoplasms
Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1? under hypoxic conditions in Hep-2 human cells.
Neoplasms
Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75.
Neoplasms
Regulatory effect of chemerin and therapeutic efficacy of chemerin?9 in pancreatogenic diabetes mellitus.
Neoplasms
Relations of TGF-beta1 with HIF-1alpha, GLUT-1 and longer survival of colorectal cancer patients.
Neoplasms
Relationship between (18)F-FDG uptake on PET and various biologic molecular markers in benign pulmonary lesion: comparison with primary lung cancer.
Neoplasms
Relationship between (18)F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Neoplasms
Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Neoplasms
Relationship Between Tumor Immune Markers and Fluorine-18-?-Methyltyrosine ([18F]FAMT) Uptake in Patients with Lung Cancer.
Neoplasms
Restoration of adipose function in obese, glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein ? upregulation.
Neoplasms
Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer.
Neoplasms
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Neoplasms
Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
Neoplasms
ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer.
Neoplasms
Salicylketoximes That Target Glucose Transporter?1 Restrict Energy Supply to Lung Cancer Cells.
Neoplasms
Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.
Neoplasms
Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.
Neoplasms
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.
Neoplasms
Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
Neoplasms
Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
Neoplasms
Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3?/?-catenin/survivin signaling pathway in breast cancer cells.
Neoplasms
Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women.
Neoplasms
Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy.
Neoplasms
Solid tumours arising from differently pre-oxygenated cells: comparable growth rates despite dissimilar tissue oxygenation.
Neoplasms
Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines.
Neoplasms
Strategy for identification of novel glucose transporter family members by using internet-based genomic databases.
Neoplasms
Sublethal exposures of diazinon alters glucose homostasis in Wistar rats: Biochemical and molecular evidences of oxidative stress in adipose tissues.
Neoplasms
Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.
Neoplasms
Sustain, Adapt, and Overcome-Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia.
Neoplasms
Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Neoplasms
Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.
Neoplasms
Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-d-g1ucose modified SPIOs.
Neoplasms
Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma.
Neoplasms
Targeting HIF2? translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
Neoplasms
Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
Neoplasms
The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.
Neoplasms
The BRAF V600E Mutation in Papillary Thyroid Carcinomas Is Associated with Glucose Transporter 1 Overexpression.
Neoplasms
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.
Neoplasms
The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Neoplasms
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Neoplasms
The Effect of Carbogen Breathing on 18F-FDG Uptake in Non-Small-Cell Lung Cancer.
Neoplasms
The effect of PPAR-gamma agonist on 18F-FDG uptake in tumor and macrophages and tumor cells.
Neoplasms
The effects of fish oil on gene expression in patients with polycystic ovary syndrome.
Neoplasms
The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors.
Neoplasms
The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.
Neoplasms
The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes.
Neoplasms
The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro.
Neoplasms
The Medicinal Chemistry of Theragnostics, Multimodality Imaging and Applications of Nanotechnology in Cancer.
Neoplasms
The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.
Neoplasms
The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.
Neoplasms
The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.
Neoplasms
The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy.
Neoplasms
The Tilapia collagen peptide mixture TY001 protects against LPS-induced inflammation, disruption of glucose metabolism, and aberrant expression of circadian clock genes in mice.
Neoplasms
The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptake.
Neoplasms
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.
Neoplasms
The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer.
Neoplasms
Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.
Neoplasms
Thymol improves barrier function and attenuates inflammatory responses in porcine intestinal epithelial cells during lipopolysaccharide (LPS)-induced inflammation.
Neoplasms
Thymoquinone ameliorates obesity-induced metabolic dysfunction, improves reproductive efficiency exhibiting a dose-organ relationship.
Neoplasms
Trigonelline reduced diabetic nephropathy and insulin resistance in type 2 diabetic rats through peroxisome proliferator-activated receptor-?.
Neoplasms
Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells.
Neoplasms
Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. Regulation by the adenosine-uridine binding factor.
Neoplasms
Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes.
Neoplasms
Tumor necrosis factor-alpha regulation of glucose transporter (GLUT1) mRNA turnover. Contribution of the 3'-untranslated region of the GLUT1 message.
Neoplasms
Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.
Neoplasms
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer.
Neoplasms
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Neoplasms
UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
Neoplasms
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Neoplasms
Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Neoplasms
Usefulness of automatic quantification of immunochemical staining on whole tumor sections for correlation with oncological small animal pet studies: an example with cell proliferation, glucose transporter 1 and FDG.
Neoplasms
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.
Neoplasms
Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
Neoplasms
Variability in glucose transporter-1 levels and hexokinase activity in human melanoma.
Neoplasms
Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
Neoplasms
Vitamin C supplementation had no side effect in non-cancer, but had anticancer properties in ovarian cancer cells.
Neoplasms
Vitexin, an inhibitor of hypoxia-inducible factor-1?, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma.
Neoplasms
von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
Neoplasms
Vulnerability of Left Amygdala to Total Sleep Deprivation and Reversed Circadian Rhythm in Molecular Level: Glut1 as a Metabolic Biomarker.
Neoplasms
Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Neoplasms
Xanthine oxidase inhibitory activity and antihyperuricemic effect of Moringa oleifera Lam. leaf hydrolysate rich in phenolics and peptides.
Neoplasms
Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3.
Neoplasms
Zinc oxide nanoparticles augment CD4, CD8, and GLUT-4 expression and restrict inflammation response in streptozotocin-induced diabetic rats.
Neoplasms
[Effects of early insulin therapy on nuclear factor kappaB pathway in skeletal muscle of diabetes: experiment with rats]
Neoplasms
[Expression of glucose transporter 1 in human breast carcinoma and its clinical significance]
Neoplasms
[Inhibiting the expression of glucose transporter 1 reduces the proliferation, invasion and migration of neuroblastoma cells].
Neoplasms
[Preparation and characterization of tumor targeted CdTe quantum dots modified with functional polymer].
Neoplasms
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
Neoplasms
[Sinusoidal hemangioma: Immunohistochemical analysis with glucose transporter 1 (GLUT1) and williams tumor protein 1 (WT1)]
Neoplasms
[The preventive effect of total saponins of Panax japonicus on nonsteroidal anti-inflammatory drug-induced enteropathy].
Neoplasms
[Value of 18F-FDG metabolic imaging in diagnosis and treatment of head and neck tumors and its mechanism study]
Neoplasms, Squamous Cell
Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.
Nephrolithiasis
Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients.
Nerve Sheath Neoplasms
Claudin-1 and Glucose Transporter 1 Immunolabelling in a Canine Intraneural Perineurioma.
Nerve Sheath Neoplasms
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Nerve Sheath Neoplasms
Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Nerve Sheath Neoplasms
Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.
Nervous System Diseases
First report of GLUT1 deficiency syndrome in Chinese patients with novel and hot spot mutations in SLC2A1 gene.
Nervous System Diseases
Focal epilepsy in Glucose transporter type 1 (Glut1) defects: case reports and a review of literature.
Nervous System Diseases
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.
Nervous System Diseases
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective.
Nervous System Diseases
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes.
Nervous System Diseases
The Effects of Ketogenic Diet on Seizures, Cognitive Functions, and Other Neurological Disorders in Classical Phenotype of Glucose Transporter 1 Deficiency Syndrome.
Neural Tube Defects
Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy.
Neural Tube Defects
Glucose transporter gene expression in rat conceptus during high glucose culture.
Neurilemmoma
Glucose Transporter 3 and 1 may Facilitate High Uptake of 18F-FDG in Gastric Schwannoma.
Neurilemmoma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuroblastoma
Akt and cAMP response element binding protein mediate 17?-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line.
Neuroblastoma
Fluoxetine induces glucose uptake and modifies glucose transporter palmitoylation in human peripheral blood mononuclear cells.
Neuroblastoma
Glucose transporter GLUT8 translocation in neurons is not insulin responsive.
Neuroblastoma
Influence of glucose transporter 1 activity inhibition on neuroblastoma in vitro.
Neuroblastoma
Nucleoside 5'-phosphorothioate derivatives are highly effective neuroprotectants.
Neuroblastoma
[Inhibiting the expression of glucose transporter 1 reduces the proliferation, invasion and migration of neuroblastoma cells].
Neurodegenerative Diseases
In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases.
Neurodegenerative Diseases
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Neurodegenerative Diseases
Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
Neuroendocrine Tumors
Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Neuroendocrine Tumors
Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1? and malignant potential in pancreatic neuroendocrine tumors.
Neuroendocrine Tumors
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Neuroendocrine Tumors
Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.
Neuroendocrine Tumors
Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis.
Neurofibroma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neurofibrosarcoma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuroinflammatory Diseases
HIF-1? stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
Neuroinflammatory Diseases
PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.
Neurologic Manifestations
Novel insight into GLUT1 Deficiency Syndrome: screening for emotional and behavioral problems in youths following ketogenic diet.
Neurologic Manifestations
Phenotypic variability of GLUT1 deficiency: When is necessary to suspect?
Neurologic Manifestations
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
Neuroma
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors.
Neuronal Ceroid-Lipofuscinoses
Clinical Application of Targeted Next-Generation Sequencing Panels and Whole Exome Sequencing in Childhood Epilepsy.
Neuronal Ceroid-Lipofuscinoses
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Nevus, Pigmented
Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
Niemann-Pick Disease, Type C
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Niemann-Pick Diseases
Positron Emission Tomography in Pediatric Neurodegenerative Disorders.
Non-alcoholic Fatty Liver Disease
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
Non-alcoholic Fatty Liver Disease
Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.
Non-alcoholic Fatty Liver Disease
[Effects of pentoxifylline on hepatic nuclear factor-kappa B signaling pathway and insulin resistance in nonalcoholic steatohepatitis rats induced by fat-rich diet]
Obesity
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Obesity
?-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKK?/NF-?B and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.
Obesity
A mathematical model and computer simulation study of insulin sensitive glucose transporter regulation.
Obesity
Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue.
Obesity
Adipose Tissue, Inter-Organ Communication, and the Path to Type 2 Diabetes: The 2016 Banting Medal for Scientific Achievement Lecture.
Obesity
Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Obesity
Alterations in glucose transporter expression and function in diabetes: mechanisms for insulin resistance.
Obesity
Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity.
Obesity
Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity.
Obesity
Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
Obesity
Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.
Obesity
Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
Obesity
Downregulation of mouse intestinal Na(+)-coupled glucose transporter SGLT1 by gum arabic (Acacia Senegal).
Obesity
Effect of aging and obesity on insulin responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344 x Brown Norway rats.
Obesity
Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle.
Obesity
Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha.
Obesity
Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report.
Obesity
Gestational 30% and 40% fat diets increase brain GLUT2 and neuropeptide Y immunoreactivity in neonatal Wistar rats.
Obesity
Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice.
Obesity
GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?
Obesity
High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.
Obesity
Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats.
Obesity
MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue.
Obesity
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes.
Obesity
Polymorphisms in stearoyl coa desaturase and sterol regulatory element binding protein interact with N-3 polyunsaturated fatty acid intake to modify associations with anthropometric variables and metabolic phenotypes in Yup'ik people.
Obesity
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Obesity
Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance.
Obesity
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
Obesity
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Obesity
Suppression of GLUT4 expression in skeletal muscle of rats that are obese from high fat feeding but not from high carbohydrate feeding or genetic obesity.
Obesity
The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise.
Obesity
Trangenic and knockout rodents: novel insights into mechanisms of body weight regulation.
Obesity
[Progress of researches on mechanisms of acupuncture therapy for insulin resistance].
Obesity
[Relationships of glucose transporter 4 with cognitive changes induced by high fat diet and glucose metabolism in hippocampus].
Obesity
[STUDY RELATIVE EXPRESSION OF GENES THAT CONTROL GLUCOSE METABOLISM IN THE LIVER IN MICE WITH DEVELOPMENT OF MELANOCORTIN OBESITY].
Obesity, Maternal
Effects of maternal diet and exercise during pregnancy on glucose metabolism in skeletal muscle and fat of weanling rats.
Obesity, Maternal
Insulin stimulates GLUT4 trafficking to the syncytiotrophoblast basal plasma membrane in the human placenta.
Obesity, Maternal
Maternal obesity impairs brain glucose metabolism and neural response to hyperglycemia in male rat offspring.
Obesity, Morbid
Decreased adipocyte glucose transporter 4 (GLUT4) and aquaglyceroporin-7 (AQP7) in adults with morbid obesity: possible early markers of metabolic dysfunction.
Ocular Motility Disorders
Glucose Transporter 1 Deficiency: A Treatable Cause of Opsoclonus and Epileptic Myoclonus.
Odontogenic Cysts
Glucose Transporter 1 Expression in Odontogenic Keratocyst, Dentigerous Cyst, and Ameloblastoma: An Immunohistochemical Study.
Odontogenic Cysts
Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts.
Osteoarthritis
Programming changes in GLUT1 mediated the accumulation of AGEs and matrix degradation in the articular cartilage of female adult rats after prenatal caffeine exposure.
Osteosarcoma
Clinicopathological significance of glucose transporter protein-1 overexpression in human osteosarcoma.
Osteosarcoma
Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line.
Osteosarcoma
Glucose transporter protein 1-targeted RNA interference inhibits growth and invasion of the osteosarcoma cell line MG63 in vitro.
Osteosarcoma
Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells.
Osteosarcoma
Long non-coding RNA HAND2-AS1 targets glucose metabolism and inhibits cancer cell proliferation in osteosarcoma.
Osteosarcoma
MicroRNA-140-5p is Downregulated in Osteosarcoma and Overexpression of MicroRNA-140-5p Inhibits Cancer Cell Proliferation by Downregulating GLUT-1.
Osteosarcoma
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Osteosarcoma
Silencing of Glucose Transporter Protein-1 by RNA Interference Inhibits Human Osteosarcoma Mg63 Cells Growth in vivo.
Ovarian Neoplasms
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells.
Ovarian Neoplasms
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer.
Ovarian Neoplasms
MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
Ovarian Neoplasms
Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876.
Ovarian Neoplasms
Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Overnutrition
Maternal and postnatal overnutrition differentially impact appetite regulators and fuel metabolism.
Overweight
Impact of pre-exercise feeding status on metabolic adaptations to endurance-type exercise training.
Pancreatic Neoplasms
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis.
Pancreatic Neoplasms
Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
Pancreatic Neoplasms
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Pancreatic Neoplasms
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Pancreatic Neoplasms
Glucose and Lactate Transport in Pancreatic Cancer: Glycolytic Metabolism Revisited.
Pancreatic Neoplasms
Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Pancreatic Neoplasms
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Pancreatic Neoplasms
Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
Pancreatic Neoplasms
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
Pancreatic Neoplasms
The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1? on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
Pancreatitis
Pancreatic endocrine function and glucose transporter (GLUT)-2 expression in rat acute pancreatitis.
Pancreatitis, Chronic
Binding forces of hepatic microsomal and plasma membrane proteins in normal and pancreatitic rats: an AFM force spectroscopic study.
Pancreatitis, Chronic
Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis.
Papilloma
Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
Papilloma
Sinonasal oncocytic Schneiderian papilloma accompanied by intravascular lymphoma: A case report on FDG-PET/CT imaging.
Papilloma, Choroid Plexus
Immunohistochemical localization of the glucose transporter GLUT1 in choroid plexus papillomas.
Papilloma, Intraductal
Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.
Papillomavirus Infections
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Paraparesis, Spastic
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
Parkinson Disease
?-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons.
Parkinson Disease
Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease.
Peritoneal Fibrosis
[High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Persistent Infection
PPAR?-Mediated Increase in Glucose Availability Sustains Chronic Brucella abortus Infection in Alternatively Activated Macrophages.
Pharyngeal Neoplasms
Prognostic significance of hypoxia-inducible factor-1? expression in advanced pharyngeal cancer without human papillomavirus infection.
Pheochromocytoma
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Pituitary Neoplasms
Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
Pituitary Neoplasms
GLUT3 expression in cystic change induced by hypoxia in pituitary adenomas.
Placental Insufficiency
Transcriptomic analysis of equine chorioallantois reveals immune networks and molecular mechanisms involved in nocardioform placentitis.
Pleural Effusion, Malignant
Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: A useful diagnostic tool for malignant pleural effusions.
Pneumonia
Aerobic exercise improves LPS-induced sepsis via regulating the Warburg effect in mice.
Polycystic Ovary Syndrome
Effects of Metformin on the Expression of GLUT4 in Endometrium of Obese Women with Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.
Polycystic Ovary Syndrome
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Polycythemia
Time-course and reversibility of the hypoxia-induced alterations in cerebral vascularity and cerebral capillary glucose transporter density.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.
Prediabetic State
Evaluation of the effects of bredemolic acid on selected markers of glucose homeostasis in diet-induced prediabetic rats.
Prediabetic State
White tea intake prevents prediabetes-induced metabolic dysfunctions in testis and epididymis preserving sperm quality.
Prostatic Neoplasms
EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
Prostatic Neoplasms
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
Prostatic Neoplasms
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer.
Prostatic Neoplasms
Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Docking Studies Show That D-Glucose and Quercetin Slide through the Transporter GLUT1.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Glucose Transporter Type I Deficiency Causing Mitochondrial Dysfunction.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Implications of aberrant temperature-sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
New treatment paradigms in neonatal metabolic epilepsies.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy.
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
[Experience of using ketogenic diet in a patient with glucose transporter 1 deficiency syndrome (a case report)].
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
[GLUT-1 deficiency syndrome or De Vivo disease: a case report]
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
[Progresses in studies on the glucose transporter deficiency syndrome]
protein-npi-phosphohistidine-d-glucose phosphotransferase deficiency
[Symptomatic absence seizures, the least known causation of absence seizures].
Prurigo
[18 F]-Fluorodeoxy-D-glucose uptake in prurigo nodules induced by the membranous expression of glucose transporter.
Psoriasis
Glucose transporter member 1 is involved in UVB-induced epidermal hyperplasia by enhancing proliferation in epidermal keratinocytes.
Psoriasis
HIF-1? may promote glycolysis in psoriasis vulgaris via upregulation of CD147 and GLUT1.
Pulmonary Disease, Chronic Obstructive
Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Cellular assessment of muscle in COPD: case studies of two males.
pyruvate dehydrogenase (nadp+) deficiency
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
pyruvate dehydrogenase (nadp+) deficiency
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
pyruvate dehydrogenase (nadp+) deficiency
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
pyruvate dehydrogenase (nadp+) deficiency
Glucose transporter 1 deficiency syndrome and other glycolytic defects.
pyruvate dehydrogenase (nadp+) deficiency
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
pyruvate dehydrogenase (nadp+) deficiency
The ketogenic diet: uses in epilepsy and other neurologic illnesses.
Pyruvate Dehydrogenase Complex Deficiency Disease
Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients.
Pyruvate Dehydrogenase Complex Deficiency Disease
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
Pyruvate Dehydrogenase Complex Deficiency Disease
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
Pyruvate Dehydrogenase Complex Deficiency Disease
Food and Food Products on the Italian Market for Ketogenic Dietary Treatment of Neurological Diseases.
Pyruvate Dehydrogenase Complex Deficiency Disease
Glucose transporter 1 deficiency syndrome and other glycolytic defects.
Pyruvate Dehydrogenase Complex Deficiency Disease
Ketogenic diet for treatment of epilepsy.
Pyruvate Dehydrogenase Complex Deficiency Disease
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Pyruvate Dehydrogenase Complex Deficiency Disease
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.
Pyruvate Dehydrogenase Complex Deficiency Disease
Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
Pyruvate Dehydrogenase Complex Deficiency Disease
The ketogenic diet: uses in epilepsy and other neurologic illnesses.
Rectal Neoplasms
Clinical value of significance of Hypoxia Inducible Factor-1?, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
Rectal Neoplasms
Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
Renal Insufficiency, Chronic
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: Impact of the 2020 KDIGO clinical practice guidelines.
Respiratory Tract Infections
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID-19.
Retinal Degeneration
HIF-1? stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa.
Retinoblastoma
Differences in the expression of glucose transporter protein isoforms in human retinoblastoma cell lines.
Retinopathy of Prematurity
Retinal neovascular markers in retinopathy of prematurity: aetiological implications.
Rhabdomyosarcoma
Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas.
Rhabdomyosarcoma
Human rhabdomyosarcoma cells retain insulin-regulated glucose transport activity through glucose transporter 1.
Rhabdomyosarcoma
PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
Rhabdomyosarcoma
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Rickets, Hypophosphatemic
Mutation analysis of the GLUT2 gene in three unrelated Egyptian families with Fanconi-Bickel syndrome: revisited gene atlas for renumbering.
Salmonella Infections
Understanding the multifaceted roles of the phosphoenolpyruvate: Phosphotransferase system in regulation of Salmonella virulence using a mutant defective in ptsI and crr expression.
Sarcoma
FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background.
Sarcoma
INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Sarcoma
Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Sarcoma
The rat facilitated glucose transporter gene. Transformation and serum-stimulated transcription initiate from identical sites.
Sarcoma, Avian
Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts.
Schistosomiasis
Effect of antisense-SGTPs on the glucose uptake of the blood fluke Schistosoma mansoni: observations in adult worms and schistosomula.
Schistosomiasis
In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis.
Scleroderma, Systemic
The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
Scrapie
Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection.
Scrapie
Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance.
Seizures
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia.
Seizures
A single glucose transporter configuration in normal primate brain endothelium: comparison with resected human brain.
Seizures
Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
Seizures
Acute upregulation of blood-brain barrier glucose transporter activity in seizures.
Seizures
Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review.
Seizures
Blood-brain barrier, ion homeostatis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms.
Seizures
Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
Seizures
Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome.
Seizures
First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation.
Seizures
Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.
Seizures
Glucose transporter type 1 deficiency: Ketogenic diet in three patients with atypical phenotype.
Seizures
Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
Seizures
Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice.
Seizures
Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome.
Seizures
Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
Seizures
Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome.
Seizures
Molecular analysis and anticonvulsant therapy in two patients with glucose transporter 1 deficiency syndrome: a successful use of zonisamide for controlling the seizures.
Seizures
Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders.
Seizures
New Paradigm for the Treatment of Glucose Transporter 1 Deficiency Syndrome: Low Glycemic Index Diet and Modified High Amylopectin Cornstarch.
Seizures
Pentylenetetrazol-induced status epilepticus up-regulates the expression of glucose transporter mRNAs but not proteins in the immature rat brain.
Seizures
Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy.
Seizures
Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome.
Seizures
Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.
Seizures
SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome.
Seizures
The Effects of Ketogenic Diet on Seizures, Cognitive Functions, and Other Neurological Disorders in Classical Phenotype of Glucose Transporter 1 Deficiency Syndrome.
Seizures
The human brain GLUT1 glucose transporter: ultrastructural localization to the blood-brain barrier endothelia.
Seizures
Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
Seizures
Vulnerability of Left Amygdala to Total Sleep Deprivation and Reversed Circadian Rhythm in Molecular Level: Glut1 as a Metabolic Biomarker.
Sepsis
Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice.
Shock, Septic
Glucose transporters (GLUT1, 2, & 4) in fat, muscle and liver in a rat model of endotoxic shock.
Short Bowel Syndrome
Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.
Sleep Apnea, Obstructive
Association of glucose transporter 4 genetic polymorphisms with obstructive sleep apnea syndrome in Han Chinese general population: a cross-section study.
Sleep Apnea, Obstructive
TNF-? promotes insulin resistance in obstructive sleep apnea-hypopnea syndrome.
Sleep Apnea, Obstructive
[Association of glucose transporter 4 gene polymorphism with hypoxia caused by obstructive sleep apnea syndrome and with related inflammatory factors].
Small Cell Lung Carcinoma
[Expression of GLUT1 protein and its relationship with uptake of FDG in non-small cell lung cancer tissues.]
Squamous Cell Carcinoma of Head and Neck
A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.
Squamous Cell Carcinoma of Head and Neck
Coexpression of hypoxia-inducible factor-1? and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Squamous Cell Carcinoma of Head and Neck
Glucose Transporter 1 Overexpression in Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Inhibition of microRNA-218 promotes oral squamous cell carcinoma growth by targeting GLUT1 to affect glucose metabolism.
Squamous Cell Carcinoma of Head and Neck
miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Squamous Cell Carcinoma of Head and Neck
[Expression of glucose transporter 1 in human laryngeal squamous cell carcinoma and its clinical significance].
Starvation
2-Deoxyglucose Impairs Saccharomyces cerevisiae Growth by Stimulating Snf1-Regulated and ?-Arrestin-Mediated Trafficking of Hexose Transporters 1 and 3.
Starvation
3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.
Starvation
A glucose transporter chimera confers a dominant negative glucose starvation phenotype in Saccharomyces cerevisiae.
Starvation
Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes.
Starvation
Genome-wide identification and characterization of glucose transporter (glut) genes in spotted sea bass (Lateolabrax maculatus) and their regulated hepatic expression during short-term starvation.
Starvation
Glucose transporter expression and glucose utilization in skeletal muscle and brown adipose tissue during starvation and re-feeding.
Starvation
Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells.
Starvation
Loss of fermentative capacity in baker's yeast can partly be explained by reduced glucose uptake capacity.
Starvation
Molecular identification of glucose transporter 4: The responsiveness to starvation, glucose, insulin and glucagon on glucose transporter 4 in common carp (Cyprinus carpio L.).
Starvation
Transcriptional response to glucose starvation and functional analysis of a glucose transporter of Neurospora crassa.
Starvation
Variable Effects of Autophagy Induction by Trehalose on Herpesviruses Depending on Conditions of Infection.
Starvation
[The effects of phosphorus, glucose and cytokinin on SEN1 gene expression in Arabidopsis]
Status Epilepticus
Pentylenetetrazol-induced status epilepticus up-regulates the expression of glucose transporter mRNAs but not proteins in the immature rat brain.
Stomach Neoplasms
Correlation and expression analysis of hypoxia-inducible factor 1?, glucose transporter 1 and lactate dehydrogenase 5 in human gastric cancer.
Stomach Neoplasms
Differential effects of 5-fluorouracil on glucose transport and expressions of glucose transporter proteins in gastric cancer cells.
Stomach Neoplasms
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Stomach Neoplasms
Glucose uptake in the human gastric cancer cell line, MKN28, is increased by insulin stimulation.
Stomach Neoplasms
Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.
Stomach Neoplasms
MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells.
Stomach Neoplasms
p38MAPK Signaling Enhances Glycolysis Through the Up-Regulation of the Glucose Transporter GLUT-4 in Gastric Cancer Cells.
Stomach Neoplasms
Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression.
Stomach Neoplasms
Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
Stomach Neoplasms
[Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis.]
Stroke
Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke.
Stroke, Lacunar
[Immunohistochemistry using antibody to the glucose transporter 3 in human brainstem and cerebellar tissues]
succinate-semialdehyde dehydrogenase [nad(p)+] deficiency
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
Thrombocytopenia
Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: Clinical Features and Response to Sirolimus.
Thrombosis
Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.
Thymoma
Calorie restriction initiated at a young age activates the Akt/PKCzeta/lambda-Glut4 pathway in rat white adipose tissue in an insulin-independent manner.
Thymoma
Extract from Dioscorea batatas ameliorates insulin resistance in mice fed a high-fat diet.
Thymoma
Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats.
Thymoma
Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.
Thyroid Cancer, Papillary
Association Between (18)F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
Comparison of (18)F-Fluorodeoxyglucose Uptake with the Expressions of Glucose Transporter Type 1 and Na(+)/I(-) Symporter in Patients with Untreated Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
The BRAF V600E Mutation in Papillary Thyroid Carcinomas Is Associated with Glucose Transporter 1 Overexpression.
Thyroid Cancer, Papillary
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas.
Thyroid Neoplasms
Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Thyroid Neoplasms
Expression of hypoxia inducible factor 1? and 2? and its association with vitamin C level in thyroid lesions.
Thyroid Neoplasms
Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Thyroid Neoplasms
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Thyroid Neoplasms
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Thyroid Neoplasms
Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study.
Thyroid Neoplasms
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells.
Thyroid Nodule
GLUT1 glucose transporter expression in benign and malignant thyroid nodules.
Triple Negative Breast Neoplasms
Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake.
Triple Negative Breast Neoplasms
[Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells].
Tuberculosis
Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block.
Tuberous Sclerosis
[The effect of downregulation of MCT1 on the proliferation of glioma cells].
Typhoid Fever
The central metabolism regulator EIIAGlc switches Salmonella from growth arrest to acute virulence through activation of virulence factor secretion.
Urea Cycle Disorders, Inborn
[Dietary advice for treatment of inborn errors of metabolism in adult neurology: principes and limitations]
Uremia
Insulin resistance and altered glucose transporter 4 expression in experimental uremia.
Urinary Bladder Neoplasms
MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
Urinary Bladder Neoplasms
[Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]
Uterine Cervical Neoplasms
Correlation Between FDG Uptake by PET/CT and the Expressions of Glucose Transporter Type 1 and Hexokinase II in Cervical Cancer.
Uterine Cervical Neoplasms
GLUT1 expression in human papillomavirus-positive anogenital lesions.
Uterine Cervical Neoplasms
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy.
Uterine Cervical Neoplasms
Significance of hypoxia in uterine cervical cancer. Multicentre study.
Vascular Malformations
Congenital vascular malformations--cerebral lesions differ from extracranial lesions by their immune expression of the glucose transporter protein GLUT1.
Vascular Malformations
Intraosseous 'haemangioma' of the zygoma: more appropriately termed a venous malformation.
Vascular Malformations
MRI molecular imaging using GLUT1 antibody-Fe3O4 nanoparticles in the hemangioma animal model for differentiating infantile hemangioma from vascular malformation.
Vascular Malformations
Vascular Lesions: GLUT-1 Expression as a Diagnostic Tool to Discriminate Tumors From Malformations.
Vascular Neoplasms
[Posterior mediastinum infantile hemangioma in an 11 months infant, an unusual finding. A case report and review of the literature].
Vesicular Stomatitis
Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Virus Diseases
Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter.
Whooping Cough
Glucose transport stimulation by bradykinin in Swiss 3T3 fibroblasts: a pertussis toxin-sensitive mechanism operates without involvement of arachidonic acid and cyclic AMP.
Wilms Tumor
Decreased expression of orexin 1 receptor in adult mice testes during alloxan-induced diabetes mellitus perturbs testicular steroidogenesis and glucose homeostasis.
Wilms Tumor
High NOV/CCN3 expression during high-fat diet pregnancy in mice affects GLUT3 expression and the mTOR pathway.
Wilms Tumor
Microvenular Hemangioma Presenting With Numerous Bilateral Macules, Patches, and Plaques: A Case Report and Review of the Literature.
[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase deficiency
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase deficiency
Ketogenic diet for treatment of epilepsy.
[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase deficiency
Metabolic epilepsies amenable to ketogenic therapies: Indications, contraindications, and underlying mechanisms.
[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase deficiency
Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet.
html completed